Endophytic fungi: a reservoir of antibacterials.

Multidrug drug resistant bacteria are becoming increasingly problematic particularly in the under developed countries of the world. The most important microorganisms that have seen a geometric rise in numbers are Methicillin resistant Staphylococcus aureus, Vancomycin resistant Enterococcus faecium, Penicillin resistant Streptococcus pneumonia and multiple drug resistant tubercule bacteria to name a just few. New drug scaffolds are essential to tackle this every increasing problem. These scaffolds can be sourced from nature itself. Endophytic fungi are an important reservoir of therapeutically active compounds. This review attempts to present some data relevant to the problem. New, very specific and effective antibiotics are needed but also at an affordable price! A Herculean task for researchers all over the world! In the Asian subcontinent indigenous therapeutics that has been practiced over the centuries such as Ayurveda have been effective as "handed down data" in family generations. May need a second, third and more "in-depth investigations?"

Introduction

The last two decades have witnessed a rise in the numbers of Methicillin resistant Staphylococcus aureus (MRSA), Vancomycin resistant Enterococcus faecium (VRE) and Penicillin resistant Streptococcus pneumoniae (PRSP) and a variety of antibiotics (Menichetti, 2005). New drugs such as Linezolid and Daptomycin have already acquired resistance (Mutnick et al., 2003; Skiest, 2006). MDR- and XDR-TB (Gillespie, 2002; LoBue, 2009) are emerging global threats, being difficult to diagnose, expensive to treat and with variable results. Rice (2008) reported that the ESKAPE organism's E. faecium, S. aureus, Klebsiella pneumoniae, Acinetobacter baumanii, P. aeruginosa, and Enterobacter species are the main causative agents of infections in a majority of US hospitals. To combat all these continuing developments, a search for new and novel drugs scaffolds remains the high priority activity.

Eighty five years after the discovery of Penicillin in 1929, scientists all over the world continue to investigate natural products. The novelty of structures and scaffolds, their varied bioactivities plus their abilities to act as lead molecules is immense. According to Newman and Cragg (2012), in the years 1981–2010, ~50% of all small molecules originated from natural products. Mainly antibacterial, anticancer, antiviral and antifungals compounds from natural sources such as plant, fungi and bacteria themselves. The extraordinary advantages of natural products as sources of biotherapeutics is beyond question.

Though diverse chemical compounds with equally diverse scaffolds and bioactivities have been reported from fungi over the years, the vast group still remains to be fully exploited. Out of ~1 million different fungal species only ~100,000 have been described (Hawksworth and Rossman, 1997). Dreyfuss and Chapela (1994) estimated that endophytic fungi, alone could be ~1 million. The genetic diversity of fungal endophytes may be a major factor in the discovery of novel bioactive compounds (Gunatilaka, 2006). The true potential of these endophytes is yet to be trapped.

From the first reports of isolation from the Lolium temulentum typically known as Darnel (ryegrass) by Freeman (1904), to the latest one from Antarctic moss (Melo et al., 2014), endophytic fungi have attracted the attention of botanists, chemists, ecologists, mycologists, plant pathologists and pharmacologists. It is estimated that each and every of the almost 300,000 plants that exist, hosts one or more endophyte (Strobel and Daisy, 2003). They occur everywhere, from the Arctic to Antarctic and temperate to the tropical climates. Endophytes reside in internal tissues of living plants but this association does not cause any immediate, overt, negative effects on the host plant (Bacon and White, 2000). According to Aly et al. (2011), the endophyte-plant host relationship is a balanced symbiotic continuum, ranging from mutualism through commensalism to parasitism. Many endophytic fungi remain quiescent within their hosts until it stressed or begins to undergo senescence. At this juncture the fungi may turn pathogenic (Rodriguez and Redman, 2008).

The impact of endophytes on our lives is seen in several of ways; from an insecticidal bio fumigant from the Muscodor albus, against adults and larvae of potato tuber moths (Lacey and Neven, 2006) to synthesis of “myco-diesel” by Gliocladium roseum, in the hope of alternate fuel options (Strobel et al., 2008). Between these extremes, endophytes has been shown to produce several pharmacologically important compounds such as antimycotics Cryptocin (Li et al., 2000) and Ambuic acid (Li et al., 2001), anticancer Torreyanic acid (Lee et al., 1996), Taxol (Strobel et al., 1996), anti-inflammatory Ergoflavin (Deshmukh et al., 2009), antidiabetic (nonpeptidal compound L-783,281) (Zhang et al., 1999), antioxidant Pestacin (Harper et al., 2003), Isopestacin (Strobel et al., 2002), antiviral Cytonic acids A and B (Guo et al., 2000), alkaloids and polyketides Sclerotinin A (Lai et al., 2013), Cryptosporioptide (Saleem et al., 2013), enzyme inhibitors- Fusaric acid derivatives (Chen et al., 2013), Anthraquinones (Hawas et al., 2012) and immunosuppressive agents Subglutinols A and B (Lee et al., 1995).

The need for novel antibacterials to combat this increasing variety of infections becomes a priority endeavor. Endophytic fungi may be an important source for such biotherapeutics like new antibacterials against Mycobacterium tuberculosis especially in poverty ridden tropical countries of Asia. Here the need could also involve a nutritional efforts to boost the immunity in the population. Many of the compounds with their host plants are shown in Table 1.

Table 1

Antibacterial compounds reported from endophytic fungi.

Sr. No.	Fungus	Plant source	Compounds isolated	Biological activity*	References
1	Pestalotiopsis sp.	Lichen Clavaroids sp	Ambuic acid (1)	Compound (1), S. aureus (ATCC 6538) (IC50 43.9 μM)	Ding et al., 2009
	Pestalotiopsis sp.	Lichen Clavaroids sp	Ambuic acid derivative (2)	Compound (2), S. aureus (ATCC 6538) (IC50 27.8 μM)	Ding et al., 2009
2	Pestalotiopsis sp.	Rhizophora mucronata	Pestalotiopsone A (3)	Compound (3), E. faecalis (MIC 125–250 μg/mL)	Hemberger et al., 2013
3	Pestalotiopsis mangiferae1	Mangifera indica	4-(2,4,7-trioxa-bicyclo[4.1.0]heptan-3-yl) phenol (4)	Compound (4), B. subtilis and K. pneumoniae (MIC 0.039 μg/mL), E. coli and M. luteus (MIC 1.25 μg/mL), P. aeruginosa (MIC 5.0 μg/mL).	Subban et al., 2013
4	Pestalotia sp. /Unicellular marine bacterium strain CNJ-328	Co-cultured endophytic algal marine fungus/Unicellular marine bacterium strain CNJ-328	Pestalone (5)	Compound (5), MRSA (MIC 37 ng/mL), VRE (MIC 78 ng/mL)	Cueto et al., 2001
				Compound (5), S. aureus strain SG511 (MIC 3.1 μg/mL), MRSA LT-1334 (MIC 6.25 μg/mL), B.subtilis 168 (MIC 1.6 μg/mL)	Augner et al., 2013
5	Phomopsis longicolla	Dicerandra frutescens	Dicerandrols A (6), B (7), and C (8)	Compounds (6), (7) and (8), B. subtilis (zones of inhibition of 11 mm, 9.5 mm and 8.0 mm respectively) S. aureus (zones of inhibition of 10.8, 9.5 and 7.0 mm respectively) at 300 μg/disk	Wagenaar and Clardy, 2001
6	Phomopsis longicolla strain C81	Bostrychia radicans	Dicerandrol C (8)	Compound (8), S.aureus (ATCC 6538) and S. saprophyticus (ATCC 15305), (MIC of 1 and 2 μgmL)	Erbert et al., 2012
7	Phomopsis longicolla S1B4	Unidentified plant	Dicerandrol A (6), Dicerandrol B (7), Dicerandrol C (8), Deacetylphomoxanthone B (9) Fusaristatin A (10)	Compounds (6),(7), (8), (9) and (10), X. oryzae KACC 10331 (MIC of 8, 16, >16, 4 and 128 μg/mL respectively) Compound (6), S. aureus KCTC 1916, B. subtilis KCTC 1021, Clavibacter michiganesis KACC 20122, Erwinia amylovora KACC 10060, (MIC value of 0.25, 0.125, 1.0, and 32.0 μg/mL respectively)	Lim et al., 2010
8	Phomopsis longicolla S1B4	Unidentified plant	Dicerandrol A (6), Dicerandrol B (7), Dicerandrol C (8), Deacetylphomoxanthone B (9) and Monodeacetylphomoxanthone B (11)	Compound (11), X. oryzae (MIC of 32 μg/mL)	Choi et al., 2013
9	Phomopsis sp. BCC 1323	Unidentified plant	Phomoxanthone A (12) and B (13),	Compounds (12) and (13), M. tuberculosis H37Ra strain (MIC of 0.5 and 6.25 μg/mL respectively)	Isaka et al., 2001
10	Phomopsis sp.	Costus sp.	Phomoxanthone A (12)	Compound (12), B. megaterium (Zone of inhibition of 3- 4 against the concentration of 10 mg/mL)	Elsaesser et al., 2005
11	Phomopsis sp. (internal strain no. 7233)	Laurus azorica	Cycloepoxylactone (14), Cycloepoxytriol B (15)	Compounds (14) and (15), B. megaterium (moderate activity)	Hussain et al., 2009a
12	Phomopsis sp.	Teucrium scorodonia	Phomosines A-C (16–18)	Compound (16–18), B. megaterium and E. coli (moderate activity in vitro using 6 mm filter paper disc with 50 μl of a 15 mg/mL solution)	Krohn et al., 1995
13	Phomopsis sp.	Ligustrum vulgare	Phomosines A-C (16–18)	Compounds (16–18), B. megaterium (zone of inhibition with 10, 10 and 7 mm using 6 mm filter paper disc with 50 μg of compound).	Krohn et al., 2011
14	Phomopsis sp.	Adenocarpus foliolosus	Phomosine A (16) and Phomosine G (19)	Compounds (16) and (19), B. megaterium (moderate antibacterial activity)	Dai et al., 2005
15	Phomopsis sp.	Notobasis syriaca	Phomosine K (20) 2-hydroxymethyl-4β ,5α,6β -trihydroxycyclohex-2-en (21), (−)-Phyllostine (22), (+)-Epiepoxydon (23), and (+)-Epoxydon monoacetate (24)	Compound (20), Legionella pneumophila Corby, E. coli K12 and B. megaterium (strong activity). Compound (21),(22),(23) and (24), E. coli K12 and B. megaterium (moderately active)	Hussain et al., 2011
16	Phomopsis sp.	Santolina chamaecyparissus	Phomopsinone B (25) and C (26)	Compounds (25) and (26), E.coli, and B. megaterium (moderately active)	Hussain et al., 2012b
17	Phomopsis sp	Unidentified plant	Phomochromone A (27), B (28), Phomotenone (29), (1S,2S,4S)-trihydroxy-p-menthane (30)	Compounds (27–30), E. coli and B. megaterium (active)	Ahmed et al., 2011
18	Phomopsis sp.	Cistus salvifolius	Pyrenocines J-M (31–34)	Compounds (31–34), E. coli and B. megaterium (active)	Hussain et al., 2012a
19	Endophytic fungi	Urobotrya siamensis, Grewia sp., Mesua ferrea, Rhododendron lyi, Tadehagi sp., and Gmelina elliptica	3-Nitropropionic acid (35)	Compound (35), Mycobacterium tuberculosis H37Ra (MIC of 3.3 μM)	Chomcheon et al., 2005
20	Phomopsis sp.	Erythrina crista-galli	Phomol (36)	Compound (36), A. citreus and C. insidiosum (MIC of 20 and 10 μg/mL respectively)	Weber et al., 2004
21	Phoma sp.	Saurauia scaberrinae	Phomodione (37)	Compound (37), S. aureus (MIC of 1.6 μg/mL)	Hoffman et al., 2008
22	Phoma sp.	Salsola oppostifolia	Epoxydines B (38), Epoxydon (39), (4R,5R,6S)-6-acetoxy-4,5-dihydroxy-2-(hydroxymethyl) cyclohex-2-en-1-one (40), 2-chloro-6-(hydroxymethyl) benzene-1,4-diol (41), antibiotic ES-242-1 (42)	Compounds (38–42), E. coli and B. megaterium (active)	Qin et al., 2010
23	Phoma sp.	Salsola oppositifolia	(+)-Flavipucine (43), (−)-Flavipucine (44)	Compound (43), B. subtilis, S. aureus, E. coli (zone of inhibition of 16, 17, and 11 mm, respectively in disc diffusion assay at 15 μg/6 mm disc), Compound (44), B. subtilis and E. coli (MICs of 25 μg/ mL)	Loesgen et al., 2011
24	Phoma sp. NRRL 46751,	Saurauia scaberrinae	Phomapyrrolidone B (45), C (46)	Compound (45) and (46), M. tuberculosis H37Pv Microplate Alamar Blue assay (MABA) for replicating cultures (with MIC of 5.9 and 5.2 μg/mL respectively) Low oxygen recovery assay (LORA) (MIC 15.4 and 13.4 μg/mL respectively for nonreplicating)	Wijeratne et al., 2013
25	Colletotrichum gloeosporioides	Artemisia mongolica	Colletotric acid (47)	Compound (47), B. subtilis, S. aureus, and S. lutea (MIC of 25, 50, and 50 μg/mL)	Zou et al., 2000
26	Colletotrichum sp.	Ilex canariensis	(22E,24R)-19(10–>6)-abeo-ergosta-5,7,9,22-tetraen-3beta-ol (48), (22E,24R)-ergosta-4,7,22-trien-3-one (49), (22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one (50), (22E,24R)-ergosta-7,22-dien-3beta,5alpha,6beta-triol (51), (22E,24R)-6-acetoxy-ergosta-7,22-dien-3beta,5alpha,6beta-triol (52), and (22E,24R)-3,6-diacetoxy-ergosta-7,22-dien-3beta,5alpha,6beta-triol (53)	Compounds (48–53), E. coli and B. megaterium (active at the concentration of 0.05 μg/filter paper disc of 6 mm diameter)	Zhang et al., 2009
27	Coniothyrium sp.	Sideritis chamaedryfolia	1-hydroxy-5-methoxynaphthalene (54), 1,5-dimethoxy-4-nitronaphthalene (55), 1- hydroxy-5-methoxy-2,4-dinitronaphthalene (56)	Compounds (54–56), E. coli and B. megaterium (active)	Krohn et al., 2008a
28	Coniothyrium cereale	Marine green alga Enteromorpha sp.	(−)-Trypethelone (57)	Compound (57) Mycobacterium phlei, S. aureus, and E. coli, (at 20 μg/disk zones of inhibition of 18, 14, and 12 mm respectively)	Elsebai et al., 2011
29	Coniothyrium sp	Salsola oppostifolia	Pachybasin (58), 1,7-Dihydroxy-3-methyl-9,10-anthraquinone (59), Phomarin (60) 1-Hydroxy-3-hydroxymethyl-9,10-anthraquinone (61) and Coniothyrinones A-D (62- 65)	Compounds (58–65), E. coli and B. megaterium (active at 50 μg/9 mm filter paper disc dissolved in acetone)	Sun et al., 2013a
30	Diaporthe phaseolorum	Laguncularia racemosa	3-Hydroxypropionic acid (66)	Compound (66), S. aureus and S. typhi (MIC of 64 μg/ mL)	Sebastianes et al., 2012
31	Botryosphaeria mamane PSU-M76	Garcinia mangostana	Botryomaman (67), 2,4-Dimethoxy-6-pentylphenol (68),(R)- (−)-Mellein (69), Primin (70), cis-4-hydroxymellein (71), trans-4-hydroxymellein (72), and 4,5-dihydroxy-2-hexenoic acid (73)	Compounds (67–73), S. aureus ATCC 25923 and MRSA SK1 (active). Compound (70) S. aureus ATCC 25923 and MRSA SK1 (MIC values of 8 μg/mL)	Pongcharoen et al., 2007
32	Microdiplodia sp	Lycium intricatum	Diversonol (74), Microdiplodiasol (75), Microdiplodiasone (76), Microdiplodiasolol (77) (−)-Gynuraone (78) and Ergosterol (79)	Compounds (74–79), Legionella pneumophila (active)	Siddiqui et al., 2011
33	Microdiplodia sp. KS 75-1	Pinus sp.	7,8-dihydonivefuranone A (80), 6(7)-dehydro-8-hydroxyterrefuranone (81), 6-hydroxyterrefuranone (82), Nivefuranones A (83)	Compounds (80–83), S. aureus NBRC 13276 (zone of inhibition of 15, 15, 16 and 15 mm respectively at 40 μg/per disc of 8 mm diameter)	Shiono et al., 2012
34	Microsphaeropsis arundinis	Pinus sp.	1β -hydroxy-α-cyperone (84)	Compound (84), S. aureus (CGMCC1.2465) (MIC 11.4 μg/mL)	Luo et al., 2013
35	Microsphaeropsis sp. (strain 8875)	Lycium intricatum	Microsphaeropsone A (85), Microsphaeropsone C (86), Citreorosein (87)	Compounds (85–87), E.coli and B. megaterium (active)	Krohn et al., 2009
36	Microsphaeropsis sp. (internal strain no. 7177)	Zygophyllum fortanesii	Fusidienol A (88), aromatic xanthones (89), 3,4-dihydroglobosuxanthone A (90)	Compounds (88–90), E.coli and B. megaterium (active)	Krohn et al., 2009
37	Dinemasporium strigosum	Calystegia sepium	Dinemasones A (91), B (92)	Compounds (91) and (92), B. megaterium (active)	Krohn et al., 2008b
38	Cytospora sp. CR200 and Diaporthe sp. CR146	Conocarpus erecta and Forsteronia spicata	Cytosporones D (93), E (94)	Compound (93), S. aureus, E. faecalis and E. coli (MIC of 8, 8, and 64 μg/mL respectively) Compound (94), S. aureus, E. faecalis and E. coli (MIC of 8, 8, and 64 μg/mL respectively)	Brady et al., 2000
39	Cytospora sp. CR200	Conocarpus erecta	Cytosporones D (93), E (94) Cytoskyrin A (95)	Compound A (95), S. aureus ATCC 29923, S. aureus ATCC6538P, S. aureus #310 (MRSA), E. faecium #379 (VREF), E. faecium #436 (VSEF), B. subtilis BGGS1A1, E. coli imp BAS849, E. coli BAS849, E. coli ATCC25922, K. pneumoniae ATCC 10031, P. aeruginosa ATCC 27079 (MICs 0.03–0.25 μg/mL) and compound (93) and (94), Above mentioned bacteria (MICs 8–64 μg/mL)	Singh et al., 2007
40	Cytospora sp.	Ilex canariensis	(R)-5-((S)-hydroxy(phenyl)-methyl) dihydrofuran-2(3H)-one (96) and its 6-acetate (97), a new naphthalenone derivative (98), (S)-5-((S)-hydroxy(phenyl)-methyl)dihydrofuran-2(3H)-one (99), (S)-5-benzyl-dihydrofuran-2(3H)-one (100), 5-phenyl-4-oxopentanoic acid (101), gamma-oxo-benzenepentanoic acid methyl ester (102), 3-(2,5-dihydro-4-hydroxy-5-oxo-3-phenyl-2-furyl)propionic acid (103), (3R)-5-methylmellein (104), Integracins A (105) and B (106)	Compounds (96–106), B. megaterium (zone size in the range of 15–25 mm when 50 μl of the solution (0.05 mg substance) were pipetted onto a sterile filter disc 9 mm)	Lu et al., 2011
41	Chaetomium globosum	Viguiera robusta	Chaetoglobosin B (107)	Compound (107), S. aureus (MIC 120 μg/mL) and E. coli (MIC 189 μg/mL)	Momesso et al., 2008
42	Chaetomium globosum strain IFB-E036	Cynodon dactylon	Chaetoglocins A (108), B (109)	Compounds (108) and (109), B. subtilis, S. pyogens, M. luteus and M. smegmatis (MIC between 8 and 32 μg/mL)	Ge et al., 2011
43	Chaetomium globosum SNB-GTC2114	Paspalum virgatum	Acremonisol A (110), Semicochliodinol A (111), Cochliodinol (112)	Compounds (110), (111) and (112), S. aureus ATCC 29213 (MIC of 64, 2 and 4 μg/mL respectively)	Casella et al., 2013
44	Lewia infectoria SNB-GTC2402	Besleria insolita	Pyrrocidine A (113) Pyrrocidine B (114) Pyrrocidine C (115), Alterperylenol (116)	Compounds (113–114), S. aureus ATCC 29213, (MIC value of 5 μg/ mL) Compounds (115), and (116), S. aureus ATCC 29213 (MIC of 2, and 32 μg/mL respectively)	Casella et al., 2013
45	Xylaria sp.	Ginkgo biloba	7-amino-4-methylcoumarin (117)	Compound (117), S. aureus, E. coli, S. typhi, S. typhimurium, S.enteritidis, A. hydrophila, Yersinia sp., V. anguillarum, Shigella sp., and V. parahaemolyticus (MIC of 16, 10, 20 15, 8.5, 4, 12.5, 25, 6.3, and 12.5 μg/mL respectively)	Liu et al., 2008
46	Xylaria sp.	Torreya jackii	1-(xylarenone A) xylariate A (118), Xylarioic acid B (119), Xylariolide A (120), Xylariolide B (121), Xylariolide C (122), Me xylariate C (123), xylariolide D (124), Taiwapyrone (125)	Compounds (118–125), E. coli ATCC 25922, B. subtilis ATCC 9372, and S. aureus ATCC 25923 (MIC values above 10 μg/mL)	Hu et al., 2010
47	Cryptosporiopsis sp.,	Viburnum tinus	Cryptosporioptide (126)	Compound (126), B.megaterium (with a 9 mm radius of the zone of inhibition (50 μg/9 mm paper disc)	Saleem et al., 2013
48	Microdochium bolleyi	Fagonia cretica	Monocerin (127), (12S)-12-Hydroxymonocerin (128), Isocoumurin (129)	Compounds (127–129), E. coli and B. megaterium (active)	Zhang et al., 2008a
49	Chalara sp. strain 6661	Artemisia vulgaris	Isofusidienol A, B, C, and D (130–133)	Compounds (130) and (131), B. subtilis (with zone of inhibition 23 and 22 mm respectively, (15 μg/6-mm filter disks). Compound (130), S. aureus and E. coli (With zone of inhibition 9 and 8 mm, (15 μg per 6-mm filter disks). Compounds (132) and (133), B. subtilis (With zone of inhibition of 9 and 8 mm against (15 μg per 6-mm filter disks)	Loesgen et al., 2008
50	Blennoria sp.	Carpobrotus edulis	Secalonic acid B (134) Blennolides A (135), and B (136)	Compounds (134–136), B. megaterium (active), Compounds (135) and (136), E.coli (active)	Zhang et al., 2008b
51	Preussia sp.	Aquilaria sinensis	Spiropreussione A (137)	Compond (137), S. aureus (CMCC B26003) (Zone of inhibition of 16.4 ± 0.3 mm (n = 3) at 5 μg/disk, MIC 25 μM)	Chen et al., 2009
52	Guignardia sp. IFB-E028	Hopea hainanensis	Monomethylsulochrin (138), Rhizoctonic acid (139), Guignasulfide (140)	Compounds (138–140), Helicobacter pylori (MIC values of 28.9, 60.2, and 42.9 μM, respectively)	Wang et al., 2010
53	Pichia guilliermondii Ppf9	Paris polyphylla var. yunnanensis	Helvolic acid (141)	Compound (141), A. tumefaciens, E. coli, P. lachrymans, R. solanacearum, X. vesicatoria, B. subtilis, S. aureus and S.haemolyticus,(MICs 1.56, 3.13, 3.13, 1.56, 1.56,3.13, 50, and 6.25 μg/mL)	Zhao et al., 2010
54	Sordariomycete sp.strain B5	Eucommia ulmoides Oliver	Chlorogenic acid (142)	Compound (142), (Antibacterial, antifungal, antioxidant, and antitumor activities)	Chen et al., 2010
55	Biscogniauxia formosana BCRC 33718	Cinnamomum sp.	Biscogniazaphilones A (143) and B (144), N-trans-feruloy-3-O-methyldopamine (145) 5-hydroxy-3,7,40-trimethoxyflavone (146) 4-methoxycinnamaldehyde (147) methyl 3,4-methylenedioxycinnamate (148) 4-methoxy-trans-cinnamic acid (149)	Compounds (143) and (144), M. tuberculosis strain H37Rv. (MIC values of ≤5.12 and ≤2.52 μg/mL). Compounds (145–149), M. tuberculosis strain H37Rv. (MICs 12.5, 25.0, 42.1, 58.2, and 50.0 μg/mL)	Cheng et al., 2012
56	Dothideomycete sp.	Tiliacora triandra	Dothideomycetide A (150)	Compound (150), S. aureus ATCC 25923 and MRSA ATCC 33591 (MICs 128 and 256 μg/mL respectively)	Senadeera et al., 2012
57	Eurotium cristatum EN-220	Sargassum thunbergii	Cristatumins A (151), Tardioxopiperazine A (152)	Compounds (151) and (152), E. coli and S. aureus (MICs 64 and 8 μg/mL)	Du et al., 2012
58	Aspergillus sp. CY725	Cynodon dactylon	Helvolic acid (141), Monomethylsulochrin (138), ergosterol (79), 3β -hydroxy-5α,8α-epidioxy- ergosta-6,22-diene (153)	Compounds (141), (138), (79), and (153), H. pylori (MICs of 8.0, 10.0, 20.0, and 30.0μg/mL respectively). Compound (141) Sarcina lutea and S. aureus (MICs 15.0 and 20.0 μg/mL respectively)	Li et al., 2005
59	Aspergillus sp.	Mixed cultured mycelia of two marine-derived mangrove epiphytic fungi	Aspergicin (154), Neoaspergillic acid (155)	Aspergicin (154), S. aureus, S. epidermidis, B. subtilis, B. dysenteriae, B. proteus, and E. coli, (MIC of 62.5, 31.25 15.62, 15.62 62.5, and 31.25 μg/mL respectively) Compound (155), S. aureus, S. epidermidis, B. subtilis, B. dysenteriae, B. proteus, and E. coli, (MIC of 0.98, 0.49, 1.95, 7.8, 7.8, and 15.62 μg/mL respectively)	Zhu et al., 2011
60	Aspergillus sp.	Bruguiera gymnorrhiza	Aspergillumarin A (156), B (157)	Compounds (156) and B (157), S. aureus and B. subtilis (active at 50 μg/mL)	Li et al., 2012
61	Aspergillus versicolor	Brown alga Sargassum thunbergii	Brevianamide M (158), 6,8-di-O-methylaverufin (159), 6-O-methylaverufin (160),	Compounds (158–160), S. aureus and E. coli (active)	Miao et al., 2012
62	Aspergillus versicolor	Red Sea green alga Halimeda opuntia	Isorhodoptilometrin-1-Me ether (161), Siderin (162),	Compounds (161, 162), B. cereus, B. subtilis and S. aureus (actve at 50 μg/disc of 9 mm)	Hawas et al., 2012
63	Aspergillus wentii pt-1	Red alga Gymnogongrus flabelliformis	Yicathin B(163), Yicathin C (164)	Compound (163), E. coli (inhibition diameter 9 mm) and (164), E. coli (12.0 mm) and S. aureus (7.5 mm) at 10 mg/disk	Sun et al., 2013b
64	Aspergillus sp. EJC08	Bauhinia guianensis	Fumigaclavine C (165), Pseurotin A (166)	Compound (165), B. subtilis, E. coli, P. aeruginosa and S. aureus (MICs 7.81 62.50 31.25 15.62 μg/mL). Compound (166), B. subtilis, E. coli, P. aeruginosa and S. aureus (MICs 15.62 31.25 31.25 15.62 μg/mL)	Pinheiro et al., 2013
65	Penicillium sclerotiorum PSU-A13.		(+)-Sclerotiorin (167),	Compound (167), S. aureus sub sp.aureus ATCC 29213, (MIC 128 μg/mL)	Lucas et al., 2007; Arunpanichlert et al., 2010
66	Penicillium janczewskii	Prumnopitys analina	Pseurotin A (166)	Compond (166), E. carotovora and P. syringae, (IC50 values of 220 and 112 μg/mL)	Schmeda-Hirschmann et al., 2008
67	Penicillium citrinumstrain ZD6	Bruguiera gymnorrhiza	Emodin (168), Erythritol (169)	Compounds (168) and (169), B. subtilis (MICs 25μg/mL and 50μg/mL respectively), Compound (168) P. aeruginosa (MIC 100 μg/mL)	Li et al., 2010
68	Penicillium chrysogenum QEN-24S	Marine red alga Laurenciasp	Conidiogenone B (170), Conidiogenol (171)	Compound (170), MRSA, P. fluorescens, P. aeruginosa, and S. epidermidis (each with a MIC value of 8 μg/mL), Compound (171), P. fluorescens and S. epidermidis (each with a MIC value of 16 μg/mL)	Gao et al., 2011
69	Penicillium chrysogenum MTCC 5108	Porteresia coarctata	3,1'-didehydro-3[2”(3'”,3'”-dimethyl-prop-2-enyl)-3”-indolylmethylene]-6-Me pipera-zine-2,5-dione (172)	Compound (172), Vibrio cholera MCM B-322 (active)	Devi et al., 2012
70	Penicillium citrinum	Ocimum tenuiflorum	Perinadine A (173), Alternariol (174), Citrinin (175)	Compounds (173–175), S. aureus ATCC 29213 (MIC 64 μg/mL)	Lai et al., 2013
71	Fusarium sp. IFB-121	Quercus variabilis	(2S,2'R,3R,3'E,4E,8E,10E)-1-O-β -D-glucopyranosyl-2-N-(2'-hydroxy-3'-octadecenoyl)-3-hydroxy-9-methyl-4,8,10-sphingatrienine (176), and (2S,2'R,3R,3'E,4E,8E)-1-O-β -D-glucopyranosyl-2-N-(2'-hydroxy-3'-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (177)	Compound (176) and (177), B. subtilis, E. coli and P. fluorescens (MICs 3.9, 3.9, and 1.9 μg/mL and 7.8, 3.9, and 7.8 μg/mL respectively)	Shu et al., 2004
72	Fusarium sp. YG-45	Maackia chinensis	Fusapyridon A (178)	Compound (178), P. aeruginosa and S. aureus, (MICs 6.25 and 50 μg/mL respectively)	Tsuchinari et al., 2007
73	Fusarium redolens Dzf2	Dioscorea zingiberensis	Beauvericin (179)	Compound (179), B. subtilis, E. coli, S. hemolyticus, P. lachrymans, A. tumefaciens, and X. vesicatoria (IC50 values between 18.4 and 70.7 μg/mL)	Xu et al., 2010b
74	Fusarium oxysporum	Cinnamomum kanehirae	Beauvercin(179), (−)-4, 6'-anhydrooxysporidinone (180)	Compound (179), MRSA and B.subtilis (MICs 3.125 μg/mL). Compound (180), MRSA (MIC 100 μg/mL) and B.subtilis (MIC 25 μg/mL)	Wang et al., 2011
75	Fusarium sp. BCC14842	Bamboo	Javanicin (181), 3-O-methylfusarubin (182), compounds (183) and (184)	Compound (181), (183), antimycobacterial activity (MICs of 25μg/mL) Compound (182) and (184), antimycobacterial activity (MICs of 50 μg/mL)	Kornsakulkarn et al., 2011
76	Fusarium sp.	Mangrove plant	Cadmium (185) and copper (186) metal complexes of Fusaric acid	Compounds (185) (186), Mycobacterium bovis BCG (MICs 4μg/mL) and the M. tuberculosis H37Rv strain (MICs 10 μg/mL)	Pan et al., 2011
77	Fusarium solani	Ficus carica	Fumitremorgin B (187), Fumitremorgin C (188), Helvolic acid (141), Bisdethiobis (methylthio) gliotoxin (189), Bis-N-norgliovietin (190), Gliotoxin (191)	Compounds (187–191), B. subtilis, S. aureus, and E. coli and P. aeruginosa (MIC in the range of 0.5–16 μg/mL)	Zhang et al., 2012
78	Coculturing the fungal endophyte Fusarium tricinctum with the bacterium Bacillus subtilis 168 trpC2	Aristolochia paucinervis	Lateropyrone (192), Enniatins B1 (193), A1 (194)	Compounds (193) (194), B. subtilis (MICs 16 and 8 μg/mL respectively), and S. aureus, S. pneumoniae, and E. faecalis (MICs in the range 2-8 μg/mL). Compound (192), B. subtilis, S. aureus, S. pneumoniae, and E. faecalis (MICs in the range 2–8 μg/mL). Compounds (192–194), were effective against a multiresistant clinical isolate of S. aureus	Ola et al., 2013
79	Fusarium solani	Rheum palmatum L.	Rhein (195)	Compound (195), S. aureus, S. aureus nor A, B. megaterium 11561, P. syringae and S. meliloti (MICs in the range of 0.6–4 μg/mL)	You et al., 2013
80	Fusarium proliferatum BLH51	Macleaya cordata	Sanguinarine (196)	Sanguinarine (196), 15 clinical isolates of S. aureus (MIC range of 3.12–6.25 μg/mL) Two reference strains ATCC 25923 (MIC are 3.12 μg/mL), ATCC 33591 (MIC 1.56 μg/mL)	Wang et al., 2014
81	Trichoderma ovalisporum strain PRE-5	Panax notoginseng	Shikimic acid (197),	Compound (197) S. aureus, Bacillus cereus, M. luteus and E. coli (Active)	Dang et al., 2010
82	Trichoderma sp. PR-35	Paeonia delavayi	Trichoderic acid (198), 2β -hydroxytrichoacorenol (199), Cyclonerodiol (200), Cyclonerodiol oxide (201), and Sorbicillin (202)	Compounds (198–202), E. coli and S. albus (MIA values in the range of 25– 150 mg/disk). Compounds (198), (200), and (201), S. sonnei (MIA values in the range of 100- 150 μg/disk)	Wu et al., 2011
83	Trichoderma asperellum	Panax notoginseng	PF1022F (203), Halobacillin (204)	Compounds (203) and (204), E.faecium (CGMCC 1.2025) (IC50 7.30 and 5.24 μM respectively), S. aureus COL (CGMCC 1.2465) (IC50 19.02 and 14.00 μM respectively)	Ding et al., 2012
84	Nigrospora sp. MA75	Pongamia pinnata	Tetrahydrobostrycin (205), 4-deoxytetrahydrobostrycin (206), 3,6,8-trihydroxy-1-methylxanthone (207), Griseophenone C (208) and 2,3-didehydro-19α-hydroxy-14-epicochlioquinone B (209)	Compound (209), MRSA, E. coli, P.aeruginosa, P. fluorescens, and S. epidermidis (MICs 8, 4, 4, 0.5, and 0.5 μg/mL, respectively). Compound (208), MRSA, E. coli, P. aeruginosa, and P. fluorescens (MICs 0.5, 2, 0.5, and 0.5 μg/mL respectively). Compound (205), MRSA and E. coli (MIC 2 and 0.5 μg/mL, respectively), Compound (206), E. coli (MIC 4 μg/mL) Compound (207), S. epidermidis (MIC 0.5 μg/mL)	Shang et al., 2012
85	Nigrospora sp	Plant collected from South China Sea	4-deoxybostrycin (210), Nigrosporin (211)	Compounds (210) and (211), M. tuberculosis and clinical multidrug-resistant (MDR) M. tuberculosis strains (MICs <5 - > 60 μg/mL)	Wang et al., 2013b
86	Periconia sp.	Taxus cuspidata	Periconicins A (212) and B (213)	Compounds (212), B. subtilis, S. aureus, K. pneumoniae, and Salmonella typhimurium (MICs in the range of 3.12–12.5 μg/mL) Compounds (213), B. subtilis, S. aureus, K. pneumoniae, and Salmonella typhimurium (MICs in the range of 25–50 μg/mL)	Kim et al., 2004
87	Periconia sp.	Piper longum	Piperine (214)	Compound (214), M. tuberculosis and M. smegmetis (MIC of 1.74 and 2.62 μg/mL respectively)	Verma et al., 2011
88	Periconia siamensis CMUGE015	Thysanoleana latifolia	Modiolide A, (5, 8-dihydroxy-10-methyl-5, 8, 9, 10-tetrahydro-2H-oxecin-2-one) (215), 4-Chromanone, 6-hydroxy-2-methyl- (5CI) (216)	Compound (215), B. cereus, L. monocytogenes, MRSA, P. aeroginosa and E. coli (MIC of 3.12, 6.25, 25.00, 12.50 and 50.00 μg/mL respectively) Compound (216), B. cereus, L. monocytogenes, MRSA, P. aeruginosa and E. coli (MIC of 6.25, 12.50, 50.00 25.00, 12.50 and 100.00 μg/mL respectively)	Bhilabutra et al., 2007
89	Alternaria sp.	Sonneratia alba	Xanalteric acids I (217) and II (218), Altenusin (219)	Xanalteric acids I (217) and II (218), Multidrug-resistant S. aureus (MIC 250–125 μg/mL respectively). Altenusin (219), MRSA, S. pneumonia, E. faecium, E. cloacae and A. faecalis (MIC values of 31.25–125 μg/mL)	Kjer et al., 2009
90	Nodulisporium sp.	Juniperus cedre	1-(2,6-dihydroxyphenyl)butan-1-one (220)	Compound (220), B. megaterium (zone of inhibition 15 mm at a concentration of 0.25 mg/filter disc)	Dai et al., 2006
91	Nodulisporium sp.	Erica arborea	Nodulisporins D-F (221–223), benzene- 1,2,3-triol (224)	Compounds (221–224), B. megaterium (Active)	Dai et al., 2009b
92	Acremonium zeae	Maize plant	Pyrrocidine A (113)	Compound (113), C. michiganense subsp. nebraskense, (MIC 1–2 μg/mL), B. mojavensis (MIC 1–2 μg/mL) and P. fluorescens (MIC 1–2 μg/mL)	Wicklow and Poling, 2009
93	Rhizoctonia sp. (Cy064),	Cynodon dactylon	Rhizoctonic acid (139), Monomethylsulochrin (138), Ergosterol (79), 3β ,5α,6β -trihydroxyergosta-7,22-diene (225)	Compounds (139, 138, 79, 225), Five clinical and one reference isolate of H. pylori (ATCC 43504) (MICs in the range of 10.0–30.0 μg/mL)	Ma et al., 2004
94	Ulocladium sp.	Lichens	Ophiobolins P (226), T (227)	Ophiobolins P (226), B. subtilis and MRSA (MIC of 62.5 and 31.3 μg/mL respectively). Ophiobolin T (227), B. subtilis and MRSA S. aureus and Bacille Calmette-Guerin strain (MIC of 31.3 15.6 and 31.3 μg/mL respectively)	Wang et al., 2013a
95	Chloridium sp	Azadirachta indica	Javanicin (181)	Javanicin (181), P. fluorescens and P. aerugenosa (MIC of 2 μg/mL)	Khrawar et al., 2009
96	Botryosphaeria rhodina PSU-M35 and PSU-M114	Garcinia mangostana	(3S)-lasiodiplodin (228), (R)-(−)-mellein (229), cis-(3R,4R)-(−)-4-hydroxymellein (230), trans-(3R,4S)-(−)-4-hydroxymellein (231), (R)-(−)-5-hydroxymellein (232)	Compound (228), S. aureus and MRSA (MICs 64 and 128 μg/mL respectively), Compounds (229–232), S. aureus and MRSA (MIC value of >128 μg/mL)	Rukachaisirikul et al., 2009
97	Fusidium sp.	leaves of Mentha arvensis	Fusidilactones D (233), E (234)	Compounds (233–234), E. coli and B. megaterium (active)	Qin et al., 2009
98	Hyalodendriella sp Ponipodef12	hybrid “Neva” of Populus deltoides Marsh × P. nigra L.	Palmariol B (235), 4-hydroxymellein (236), alternariol 9-methyl ether (237), Botrallin (238)	Compounds (235–238), A. tumefaciens (IC50 values ranged from 18.22 μg/mL to 87.52 μg/mL). B. subtilis, P. lachrymans, R. solanacearum, X. vesicatoria, (MIC 19.22 μg/mL to 98.47 μg/mL, 16.18 μg/mL to 92.21 μg/mL, 16.24 μg/mL to 85.46 μg/mL, 17.81 μg/mL to 86.32 μg/mL, respectively)	Meng et al., 2012
99	Stemphylium globuliferuman	Mentha pulegium (Lamiaceae)	Alterporriol N (239), alterporriol D (240), alterporriol E (241)	Compound (239), MRSA and E. faecalis (MIC of 62.5 and 15.63μg/mL). Compound (240), MRSA and S. pneumonia (MIC of 31.25 μg/mL each) Compound (241), S. pneumonia, E. faecalis and E.cloacae (MIC of 31.25 μg/mL each)	Debbab et al., 2009
100	Endophytic fungus, no. 1403	Mangrove	Bostrycin (242)	Bostrycin (242), B. subtilis (Active)	Charudattan and Rao, 1982; Xu et al., 2010a
101	Costa Rican fungus CR115	Daphnopsis americana	Guanacastepene A (243)	Guanacastepene A (243), MRSA and VRE (Active)	Singh et al., 2000
102	Costa Rican fungus CR115	Daphnopsis americana	Guanacastepene I (244)	Guanacastepene I (244), S. aureus (Active in agar diffusion assay)	Brady et al., 2001
103	Endophytic fungus No. B77	Mangrove tree	Anhydrofusarubin (245)	Compound (245), S. aureus (ATCC27154) (MIC 12.5 μg/mL)	Shao et al., 2008b
104	Endophytic fungus B77	seed of the mangrove sample Kandelia candel	3-O-methylfusarubin (182), fusarubin (246)	Compounds (182) and (246), S. aureus ATCC 27154 (MIC value of 50.0 and 12.5 μg/mL, respectively)	Shao et al., 2008a
105	Endophytic fungus PSU-N24	Garcinia nigrolineata	Compound 2 (247), 9a –hydroxyhalorosellinia A (248) and desoxybostrycin (249)	Compound (248), M. tuberculosis (MIC 12.50 μg/mL) Compounds (247) and (249),(MIC 25 and 50 μg/mL, respectively)	Sommart et al., 2008
106	Endophytic fungus S20	Cephalotaxus hainanensis Li.	Indolyl-3-carboxylic acid (250)	Compound (250), S. aureus and MRSA (Zones of inhibition 12 and 8 mm, respectively when 50 μl (10 mg/mL) of the compound was impregnated on sterile filter paper discs (6 mm diameter)	Dai et al., 2009a
107	Endophytic fungus S20	Cephalotaxus hainanensis.	5-acyl-2-methylpyrrole (251)	Compound (251), S. aureus MRSA (Zone of inhibition of 12.0 mm and 10.0 mm respectively when 50 μl (10 mg/mL) of the compound was impregnated on sterile filter paper discs (6 mm diameter)	Dai et al., 2009c
108	Endophytic fungus Dzf12	Dioscorea zingiberensis	Diepoxin κ (252), Diepoxin η (253), Diepoxin ζ (254)	Compound (252), E. coli, A. tumefaciens, X. vesicatoria, P. lachrymansand B. subtilis (MIC ranges from 50 to 100 μg/mL). The mixture of Commpounds (253) and (254), E. coli, A. tumefaciens, X. vesicatoria, P. lachrymansand B. subtilis (MIC ranges from 5.0 to 12.5 μg/mL)	Cai et al., 2009
109	An unidentified Ascomycete	Meliotus dentatus	4-Hydroxyphthalide (255) 5-methoxy-7-hydroxyphthalide (256) (3R,4R)-cis-4-hydroxymellein (257)	Compounds (255) and (256), E. coli (Active) and compounds (256) and (257), B. megaterium (Active)	Hussain et al., 2009b
110	Unidentified ascomycete	Arbutus unedo	Pestalotheols E-H (258–261), Anofinic acid (262)	Compounds (258–262), E. coli and B. megaterium (Active)	Qin et al., 2011
111	Endophytic fungus A1	Scyphiphora hydrophyllacea	Guignardone I (263) and Guignardone B (264)	Guignardone I (263), S. aureus (MRSA) and S. aureus (Zones of inhibition of 9.0 and 11.0 mm in diameter at 65 μM, respectively (the diameter of sterile filter paper discs was 6 mm). Guignardone B (264), MRSA (zone of inhibition 8.0 mm against at 65 μM)	Mei et al., 2012
112	1223-D, an unclassified endophytic fungus	Neomirandea angularis	Mirandamycin (265)	Mirandamycin (265), E.coli 25922, P. aeruginosa 27853, K. pneumoniae carbapenemase positive BAA-1705, MRSA BAA-976 and V. cholerae PW357 (MIC of 80, 80, > 80, 10 and 40 μg/mL respectively)	Ymele-Leki et al., 2012

Data as reported by authors.

Antibacterials from endophytic fungi

Compounds from ascomycetes

Ascomycetes are an important class of fungi where there is formation of ascospores. Some genera of this class are prolific producer of bioactive metabolites. The genus Pestalotiopsis exists as an endophyte in most of the world's rainforests and is extremely biochemically diverse. Some examples of products from this group are Ambuic acid (1) and its derivative (2) (Figure 1) isolated from a Pestalotiopsis sp. of the lichen Clavaroid sp. Compounds (1) and (2) are active against S. aureus (ATCC 6538) with IC50 values of 43.9 and 27.8 μ M, respectively (the positive control Ampicillin showed an IC50 value of 1.40 μ M) (Ding et al., 2009).

Figure 1

Structures of antibacterial metabolites isolated from Ascomycetes (1–14).

Pestalotiopen A (3) (Figure 1), from Pestalotiopsis sp. of the Chinese mangrove Rhizophora mucronata exhibited moderate antimicrobial activity against Enterococcus faecalis with an MIC value between 125 and 250 μ g/mL (Hemberger et al., 2013).

A novel phenolic compound, 4-(2, 4, 7-trioxa-bicyclo [4.1.0] heptan-3-yl) phenol (4) (Figure 1) was isolated from Pestalotiopsis mangiferae associated with Mangifera indica. The compound exhibits activity against Bacillus subtilis and K. pneumoniae (MICs 0.039 μg/ml), E. coli and Micrococcus luteus (MICs 1.25 μg/ml) and P. aeruginosa (MIC 5.0 μg/ml). The positive control (Gentamycin) is showed activity against B. subtilis, K. pneumoniae and M. luteus, E. coli, and P. aeruginosa (MICs range 5.0–10.0 μg/ml). Transmission electron microscopy (TEM) analysis for mode of action of compound (4) showed that against the three human pathogens (E. coli, P. aeruginosa, and K. pneumoniae), morphological alterations took place: such as destruction of bacterial cells by cytoplasmic agglutination and formation of pores in cell wall membranes (Subban et al., 2013).

Pestalone (5) (Figure 1) is a chlorinated benzophenone antibiotic produced by a co-cultured Pestalotia sp./Unicellular marine bacterium strain CNJ-328. Pestalotia sp. was isolated from the brown alga Rosenvingea sp. collected in the Bahamas Islands. Pestalone exhibits potent activity against MRSA (MIC 37 ng/mL) and VRE (MIC 78 ng/mL), indicating that Pestalone should be evaluated in advanced models of infectious disease (Cueto et al., 2001). It is active against S. aureus strain SG511, MRSA LT-1334 and Bacillus subtilis 168 with MICs of 3.1, 6.25, and 1.6 μ g/mL respectively (Augner et al., 2013).

Phomopsis, another important genus exists as an endophyte in most plants and is also extremely biochemically diverse. Examples of bioactive metabolites from this endophyte are Dicerandrol A (6), B (7), and C (8) (Figure 1) from Phomopsis longicolla of the mint Dicerandra frutescens. They exhibit zones of inhibition of 11, 9.5, and 8.0 mm against B. subtilis respectively and 10.8, 9.5, and 7.0 mm respectively against S. aureus when tested at 300 μ g/disc (Wagenaar and Clardy, 2001).

Dicerandrol C (8) (Figure 1) was isolated from Phomopsis longicolla strain C81, from the red seaweed Bostrychia radicans. Dicerandrol C (8) had significant antimicrobial activity against S. aureus (ATCC 6538) and Staphylococcus saprophyticus (ATCC 15305), with MICs of 1 and 2 μ g /mL respectively (Erbert et al., 2012).

Dicerandrol A (6), Dicerandrol B (7), Dicerandrol C (8), Deacetylphomoxanthone B (9) and Fusaristatin A (10) (Figure 1) were isolated from Phomopsis longicolla S1B4 from a plant sample from Hadong-gun, Kyungnam Province, South Korea. All of the above compounds show moderate to low antibacterial activities against Xanthomonas oryzae KACC 10331 with MICs of 8, 16, >16, 4, and 128 μ g/mL respectively. Dicerandrol A (6) is also active against S. aureus KCTC 1916, B. subtilis KCTC 1021, Clavibacter michiganesis KACC 20122, Erwinia amylovora KACC 10060, with MICs value of 0.25, 0.125, 1.0, and 32.0 μg/mL respectively (Lim et al., 2010). Monodeacetylphomoxanthone B (11) (Figure 1) was reported from the same culture along with compounds (6–9). It is active against X. oryzae with an MIC of 32 μ g/mL (Choi et al., 2013).

Phomoxanthones A (12) and B (13) (Figure 1) were obtained from Phomopsis sp. BCC 1323, of the leaf of Tectona grandis L., from the Mee Rim district of Chaingmai Province, Northern Thailand. These compounds show significant “in vitro” antitubercular activities with MICs of 0.5 and 6.25 μg/mL respectively against Mycobacterium tuberculosis H37Ra strain, in comparison to isoniazide and kanamycin sulfate (MICs of 0.050 and 2.5 μg/mL, respectively) that are used in clinics today (Isaka et al., 2001).

Phomoxanthone A (12) (Figure 1), was also isolated from a Phomopsis sp. of the stem of Costus sp. growing in the rain forest of Costa Rica. It has activity against Bacillus megaterium at a concentration of 10 mg/mL (radius of zone of inhibition of 3–4 cm) (Elsaesser et al., 2005).

Cycloepoxylactone (14) (Figure 1) and cycloepoxytriol B (15) (Figure 2) were detected from Phomopsis sp. (internal strain no. 7233) of Laurus azorica. They are moderately active against B. megaterium (Hussain et al., 2009a).

Figure 2

Structures of antibacterial metabolites isolated from Ascomycetes (15–35).

Phomosines A–C (16–18) (Figure 2), three new biaryl ethers were obtained from Phomopsis sp. of the leaves of Teucrium scorodonia. All three compounds were moderately active against B. megaterium and E. coli in vitro, using 6 mm filter paper disc with 50 μ l each of a 15 mg/mL solution (Krohn et al., 1995). The same compounds were obtained from Phomosis sp. of Ligustrum vulgare and showed activity against B. megaterium in vitro with 10, 10, and 7 mm zone of inhibition using 6 mm filter paper disc and 50 μ g of compound (50 μ L of 1 mg/mL) respectively (Krohn et al., 2011).

Phomosine A (16) and Phomosine G (19) (Figure 2) were isolated from Phomopsis sp. of the halo tolerant plant Adenocarpus foliolosus from Gomera. Both the compound exhibited moderate antibacterial activities against B. megaterium (Dai et al., 2005).

Phomosine K (20), 2-hydroxymethyl-4β, 5α, 6β-trihydroxycyclohex-2-en (21), (−)-Phyllostine (22), (+)-Epiepoxydon (23), and (+)-Epoxydon monoacetate (24) (Figure 2) were isolated from a Phomopsis sp. of Notobasis syriaca. Phomosine K (20) is active against Legionella pneumophila Corby, E. coli K12 and B. megaterium in vitro while 2-hydroxymethyl-4β, 5α, 6β-trihydroxycyclohex-2-en (21), (−)-Phyllostine (22), (+)-Epiepoxydon (23), and (+)-Epoxydon monoacetate (24) showed moderate activities against E. coli K12 and B. megaterium (Hussain et al., 2011).

Phomopsinone B (25) and C (26) from a Phomopsis sp. present in stems of Santolina chamaecyparissus from Sardinia showed moderate activities against E.coli, and B. megaterium (Hussain et al., 2012b).

Phomochromone A (27), B (28), Phomotenone (29), and (1S, 2S, 4S)-trihydroxy-p-menthane (30) (Figure 2) were isolated from a Phomopsis sp. of Cistus monspeliensis. All three compounds (27–30) show activity against E. coli and B. megaterium (Ahmed et al., 2011).

Pyrenocines J-M (31–34) (Figure 2) were isolated from a Phomopsis sp. of the plant Cistus salvifolius, internal strain 7852. All four compounds (31–34) are active against B. megaterium and E. coli (Hussain et al., 2012a).

3-Nitropropionic acid (35) (Figure 2) was isolated from several strains of endophytic fungus of the genus Phomopsis sp. obtained from six species of Thai medicinal plants (Table 1) from the forest areas of Chiangmai, Nakhonrachasima, and Pitsanulok Provinces of Thailand. 3-Nitropropionic acid exhibits potent activity against Mycobacterium tuberculosis H37Ra with the MIC of 3.3 μ M, but no in vitro cytotoxicity was observed toward a number of cell lines (Chomcheon et al., 2005). 3-Nitropropionic acid is known to inhibit isocitrate lyase (ICL), an enzyme required for fatty acid catabolism and virulence in M. tuberculosis (Muñoz-Elías and McKinney, 2005).

Phoma is another genus which produces diverse compounds. Here are some examples of bioactive compounds produced by this genus. Phomol (36) (Figure 3), a novel antibiotic, was isolated from a Phomopsis sp. of the medicinal plant Erythrina crista-galli. Phomol is active against Arthrobacter citreus and Corynebacterium insidiosum with MICs of 20 and 10 μ g/mL respectively (Weber et al., 2004).

Figure 3

Structures of antibacterial metabolites isolated from Ascomycetes (36–47).

Phomodione (37), an usnic acid derivative was isolated from a Phoma sp. of Saurauia scaberrinae. Phomodione was found to be effective against S. aureus at a MIC of 1.6 μg/mL (Hoffman et al., 2008).

The antibacterials Epoxydine B (38), Epoxydon (39), (4R,5R,6S)-6-acetoxy-4,5-dihydroxy-2-(hydroxymethyl)cyclohex-2-en-1-one (40), 2-chloro-6-(hydroxymethyl)benzene-1,4-diol (41), and the antibiotic ES-242-1 (42) (Figure 3), were isolated from a Phoma sp. of Salsola oppostifolia. Compounds (38–42) show activity against E. coli and B. megaterium (Qin et al., 2010).

Antibacterials (+)-Flavipucine (43) and (−)-Flavipucine (44) (Figure 3), were isolated from a Phoma sp., of the plant Salsola oppositifolia. (+)-Flavipucine (43) is active against B. subtilis, S. aureus, E. coli with inhibition zones of 16, 17, and 11 mm, respectively in disc diffusion assay at 15 μ g/6 mm. (−)-Flavipucine (44) was active against B. subtilis and E. coli at MIC of 25 μ g/ mL (Loesgen et al., 2011).

Three new alkaloids, Phomapyrrolidones B-C (45–46) (Figure 3), were isolated from a Phoma sp. NRRL 46751, of the plant Saurauia scaberrinae. Phomapyrrolidones B (45) and C (46) show weak in vitro activities when tested in microplate Alamar Blue assays (MABA) with MICs of 5.9 and 5.2 μg/mL respectively and in the low oxygen recovery assay (LORA) with MICs of 15.4 and 13.4 μg/mL respectively, for nonreplicating M. tuberculosis H37Pv (Wijeratne et al., 2013).

Other endophytes of Ascomycetes are also known to produce antibacterials. For example Colletotric acid (47) (Figure 4) from Colletotrichum gloeosporioides of Artemisia mongolica or Nanjing, China inhibits B. subtilis, S. aureus, and Sarcina lutea with MICs of 25, 50, and 50 μg/mL, respectively (Zou et al., 2000).

Figure 4

Structures of antibacterial metabolites isolated from Ascomycetes (48–64).

Antibacterials (22E,24R)-19(10–>6)-abeo-ergosta-5,7,9,22-tetraen-3β-ol(48), (22E,24R)-ergosta-4,7,22-trien-3-one(49), (22E,24R)-ergosta-4,6,8(14),22-tetraen-3-one (50), (22E,24R)-ergosta-7,22-dien-3β, 5α,6β-triol (51),(22E,24R)-6-acetoxy-ergosta-7,22-dien-3β,5α,6β-triol (52), and (22E,24R)-3,6-diacetoxy-ergosta-7,22-dien-3β,5α,6β-triol (53) (Figure 4), were isolated from a Colletotrichum sp. of Ilex canariensis from Gomera. Compounds (48–53) are active against E. coli and B. megaterium of 0.05 μ g/ filter paper disc of 6 mm diameter (Zhang et al., 2009). Antibacterial 1-hydroxy-5-methoxynaphthalene (54), 1,5-dimethoxy-4-nitronaphthalene (55), 1-hydroxy-5-methoxy-2,4-dinitronaphthalene (56) (Figure 4), were isolated from Coniothyrium sp. internal strain number 7721 of the shrub Sideritis chamaedryfolia, from an arid zone near Alicante, Spain. These compounds were active against B. megaterium and E. coli (Krohn et al., 2008a).

(−)-Trypethelone (57), isolated from endophyte Coniothyrium cereale of the marine green alga Enteromorpha sp. showed activity against Mycobacterium phlei, S. aureus, and E. coli, at 20 μ g/disk with inhibition zones of 18, 14, and 12 mm, respectively (Elsebai et al., 2011).

Antibacterials Pachybasin (58), 1, 7-Dihydroxy-3-methyl-9, 10-anthraquinone (59), Phomarin (60), 1-Hydroxy-3-hydroxymethyl-9, 10-Anthraquinone (61), and Coniothyrinones A-D (62–65) (Figures 4, 5), were isolated from Coniothyrium sp., an endophyte of Salsola oppostifolia from Gomera in the Canary Islands. Compounds (58–65) were active against E. coli and B. megaterium in vitro in disc diffusion assay at 50 μ g/9 mm disc dissolved in acetone (Sun et al., 2013a).

Figure 5

Structures of antibacterial metabolites isolated from Ascomycetes (65–79).

3-Hydroxypropionic acid (3-HPA) (66) (Figure 5) was isolated from the mangrove endophyte Diaporthe phaseolorum, from branches of Laguncularia racemosa, growing in Bertioga, located in south eastern Brazil. 3-HPA was active against both S. aureus and Salmonella typhi at an MIC of 64 μ g/mL (Sebastianes et al., 2012).

Botryomaman (67), 2, 4-Dimethoxy-6-pentylphenol (68), (R)—(−)-Mellein (69), Primin (70), cis-4-hydroxymellein (71), trans-4-hydroxymellein (72) and 4, 5-dihydroxy-2-hexenoic acid (73) (Figure 5) were isolated from the endophyte Botryosphaeria mamane PSU-M76 from the leaves of Garcinia mangostana, collected in Suratthani Province, Thailand. The compounds were active against S. aureus ATCC 25923 and MRSA SK1. Primin was the most active with MIC values of 8 μ g/mL against both the strains (Pongcharoen et al., 2007).

Microdiplodia sp. isolated from the shrub Lycium intricatum gave Diversonol (74), Microdiplodiasol (75), Microdiplodiasone (76), Microdiplodiasolol (77), (−)-Gynuraone (78), and Ergosterol (79) (Figure 5). Compounds (74–79) were active against Legionella pneumophila (Siddiqui et al., 2011).

Polyketide metabolites, 7,8-dihydonivefuranone A (80), 6(7)-dehydro-8-hydroxyterrefuranone (81), 6-hydroxyterrefuranone (82) and Nivefuranones A (83) (Figure 6) were isolated from a Microdiplodia sp. KS 75-1 from the stems of conifer trees (Pinus sp.). Compounds (80–83) were active against S. aureus NBRC 13276 with zone of inhibition of 15, 15, 16, and 15 mm respectively, tested at 40 μ g/per disc of 8 mm diameter (Shiono et al., 2012).

Figure 6

Structures of antibacterial metabolites isolated from Ascomycetes (80–92).

1β-hydroxy-α-cyperone (84) (Figure 6) was isolated from the endophyte Microsphaeropsis arundinis found in stems of Ulmus macrocarpa collected from Dongling Mountain, Beijing, People's Republic of China. Compound (84) inhibits S. aureus (CGMCC1.2465), at an MIC of 11.4 μ g/mL. Ampicillin (positive control) showed an MIC value of 0.46 μ g/mL (Luo et al., 2013).

Microsphaeropsone A (85) and Microsphaeropsone C (86) (Figure 5), were isolated from Microsphaeropsis sp. (strain 8875) from the plant Lycium intricatum, co-occurs with their putative biogenetic Anthraquinoide precursors and Citreorosein (87). From a Microsphaeropsis species (strain no. 7177) of the plant Zygophyllum fortanesii from Gomera (Spain), large amounts of Fusidienol A (88) and the known aromatic xanthones (89), were isolated. The endophyte Seimatosporium species (internal strain no. 8883) of Salsola oppositifolia from Gomera (Spain), produced 3, 4-dihydroglobosuxanthone A (90). Compounds (85–90) were active against E. coli and B. megaterium (Krohn et al., 2009).

Dinemasones A(91) and B (92) (Figure 5), were isolated from Dinemasporium strigosum obtained from the roots of the herbaceous plant Calystegia sepium growing on the shores of the Baltic Sea, Wustrow, Germany. The above compounds showed antibacterial activities against B. megaterium (Krohn et al., 2008b).

Cytosporone D (93) and E (94) (Figure 7), were isolated from the endophyte CR200 (Cytospora sp.) and CR146 (Diaporthe sp.) present in tissues of Conocarpus erecta and Forsteronia spicata plants respectively collected in the Guanacaste Conservation Area of Costa Rica. Cytosporone D (93) shows antibacterial activity against S. aureus, E. faecalis, and E. coli with MICs of 8, 8, and 64 μ g/mL respectively, while Cytosporones E (94) has similar activity against S. aureus (Brady et al., 2000).

Figure 7

Structures of antibacterial metabolites isolated from Ascomycetes (93–106).

Cytosporone D (93), E (94), and Cytoskyrin A (95) (Figure 7), were isolated from a Cytospora sp. CR200 from a branch of Conocarpus erecta (Buttonwood tree) in the Guanacaste National Park, from Costa Rica. Cytoskyrin A (95) has good in-vitro antibacterial activity (MICs against (S. aureus ATCC 29923, S. aureus ATCC6538P, S. aureus #310 (MRSA), E. faecium #379 (VREF), E. faecium # 436 (VSEF), B. subtilis BGGS1A1, E. coli imp BAS849), ranging from 0.03 to 0.25 μ g/mL). Cytosporone D (93) and E (94) have moderate in-vitro antibacterial activity against above mentioned bacteria (MICs 8–64 μ g/mL) (Singh et al., 2007).

Two new benzyl γ-butyrolactone analogs, (R)-5-((S)-hydroxy(phenyl)-methyl)dihydrofuran-2(3H)-one (96) and its 6-acetate (97), a new naphthalenone derivative (98), together with aromatic derivatives, (S)-5-((S)-hydroxy(phenyl)-methyl)dihydrofuran-2(3H)-one (99), (S)-5-benzyl-dihydrofuran-2(3H)-one (100), 5-phenyl-4-oxopentanoic acid (101), gamma-oxo-benzenepentanoic acid methyl ester (102), 3-(2,5-dihydro-4-hydroxy-5-oxo-3-phenyl-2-furyl)propionic acid (103), (3R)-5-methylmellein (104), Integracins A (105), and B (106) (Figure 7) were isolated from Cytospora sp., of Ilex canariensis from Gomera. Compounds (96- 106) are active against B. megaterium, zone size range 15–25 mm when 50 μ L of a solution (0.05 mg/mL substance) are pipetted onto 9 mm a sterile filter paper disc (Lu et al., 2011).

Chaetoglobosin B (107) (Figure 8), isolated from the endophyte Chaetomium globosum from the leaves of Viguiera robusta showed weak antibacterial activity against S. aureus (MIC 120 μ g/mL) and E. coli (MIC 189 μ g/mL) (Momesso et al., 2008).

Figure 8

Structures of antibacterial metabolites isolated from Ascomycetes (107–119).

Chaetoglocins A-B (108–109) (Figure 8) isolated from Chaetomium globosum strain IFB-E036, an endophyte from Cynodon doctylon have antimicrobial activity against B. subtilis, Streptococcus pyogens, Micrococcus luteus and Mycobacterium smegmatis with MICs between 8 and 32 μ g/mL (Ge et al., 2011).

Antibacterial compounds Acremonisol A (110), Semicochliodinol A (111), Cochliodinol (112), were isolated from C. globosum SNB-GTC2114 and Pyrrocidine A (113), B (114), C (115), and Alterperylenol (116) (Figure 8) were isolated from Lewia infectoria SNB-GTC2402 obtained from Besleria insolita from the Amazon Rainforest biome of Cayenne and Roura, French Guiana. Compounds (110–112, 115, and 116), exhibited antibacterial activity against S. aureus ATCC 29213 with MICs of 64, 2, 4, 2, and 32 μg/mL respectively. Compounds (113–114) were active against S. aureus ATCC 29213, with a MIC value of 5 μ g/mL (Casella et al., 2013).

7-amino-4-methylcoumarin (117) (Figure 8) was isolated from the endophyte Xylaria sp., of Ginkgo biloba. The compound showed strong antibacterial against S. aureus, E. coli, S. typhi, Salmonella typhimurium, Salmonella enteritidis, Aeromonas hydrophila, Yersinia sp., Vibrio anguillarum, Shigella sp., and Vibrio parahaemolyticus with MIC of 16, 10, 20, 15, 8.5, 4, 12.5, 25, 6.3, and 12.5 μ g/mL respectively (Liu et al., 2008).

1-(xylarenone A)xylariate A (118), Xylarioic acid B (119) (Figure 8), Xylariolide A (120), Xylariolide B (121), Xylariolide C (122), Me-xylariate C (123), Xylariolide D (124), and taiwapyrone (125) (Figure 9), were isolated from Xylaria sp. NCY2 of Torreya jackii Chun collected from Jiangshi Nature Reserve Zone of Fujian Province, China. Compounds (118–125) are active against E. coli ATCC 25922, B. subtilis ATCC 9372 and S. aureus ATCC 25923 with MIC values above 10 μ g/mL (Hu et al., 2010).

Figure 9

Structures of antibacterial metabolites isolated from Ascomycetes (120–139).

The polyketide, Cryptosporioptide (126) (Figure 9) was isolated from a Cryptosporiopsis sp., from the shoot tissues of the shrub Viburnum tinus, collected from Gomera. At 50 μ g per 9 mm paper disc, it inhibits B. megaterium, showing a 9 mm radius of zone of inhibition (Saleem et al., 2013).

Monocerin (127), (12S)-12-hydroxymonocerin (128) and Isocoumarin (129) (Figure 9) were isolated from Microdochium bolleyi, an endophyte from Fagonia cretica. All these compounds were active against E. coli and B. megaterium (Zhang et al., 2008a).

Isofusidienol A (130), B (131), C (132), and D (133) (Figure 9) were isolated from a Chalara sp. strain 6661, an endophyte of Artemisia vulgaris, collected from Ahrenshoop, Germany Compounds (130) and (131) showed strong antibacterial activities against B. subtilis with inhibition zones of 23 and 22 mm respectively, at 15 μ g of compounds per 6-mm filter disks. Under the same conditions, 15 μ g of Penicillin G has a zone of 50-mm diameter. The MIC of compound (130) was shown to be 0.625 μ g on 6-mm filter disks. Compound (130) shows moderate activity against S. aureus and E. coli with an inhibition zone diameter of 9 and 8 mm, respectively, at 15 μ g of compound per 6-mm filter disk. Compound (132) and (133) show inhibition zone of 9 and 8 mm against B. subtilis at 15 μ g per 6-mm filter disk (Loesgen et al., 2008).

Secalonic acid B (134), Blennolides A (135) and B (136) (Figure 9) were isolated from a Blennoria sp., an endophyte of Carpobrotus edulis, from El Cedro, Gomera. Compounds (134–136) inhibit B. megaterium, and compounds (135) and (136) also inhibited E. coli (Zhang et al., 2008b).

Spiropreussione A (137) (Figure 9) was obtained from an endophyte, Preussia sp., of the mature stems of Aquilaria sinensis (Thymelaeaceae), collected from the Guangxi Medicinal Arboretum. Spiropreussione A (137) shows activity against S. aureus (CMCC B26003) with a zone of inhibition of 16.4 ± 0.3 mm (n = 3) at 5 μ g/disk. The MIC of the compound in agar dilution test using NCCLS 2002 guide lines was 25 μ M (Chen et al., 2009).

Monomethylsulochrin (138), Rhizoctonic acid (139), (Figure 9) and Guignasulfide (140) (Figure 10) were isolated from a Guignardia sp. IFB-E028, an endophyte of Hopea hainanensis and show moderate activity against the human bacterial pathogen Helicobacter pylori with MIC values of 28.9, 60.2, and 42.9 μM, respectively (Wang et al., 2010).

Figure 10

Structures of antibacterial metabolites isolated from Ascomycetes (140–152).

Helvolic acid (141) (Figure 10) was isolated from the endophyte Pichia guilliermondii Ppf9 of medicinal plant Paris polyphylla var. yunnanensis. Compound (141) has strongest antibacterial activity on Agrobacterium tumefaciens, E. coli, Pseudomonas lachrymans, Ralstonia solanacearum, Xanthomonas vesicatoria, B. subtilis, S. aureus, and Staphylococcus haemolyticus, with MICs of 1.56, 3.13, 3.13, 1.56, 1.56, 3.13, 50, and 6.25 μ g/mL, respectively (Zhao et al., 2010).

Chlorogenic acid (142) (Figure 10) was isolated from the endophyte strain B5 a Sordariomycete sp. of Eucommia ulmoides. Eucommia ulmoides is a medicinal plant of China and one of the main sources of Chlorogenic acid. It has antibacterial, antifungal, antioxidant and antitumor activities (Chen et al., 2010).

Antibacterial Biscogniazaphilones A (143) and B (144), N-trans-feruloy-3-O-methyldopamine (145), 5-Hydroxy-3,7,4-trimethoxyflavone (146), 4-Methoxycinnamaldehyde (147), Methyl 3,4-methylenedioxycinnamate (148), 4-Methoxy-trans-cinnamic acid (149), (Figure 10) were isolated from the endophyte Biscogniauxia formosana BCRC 33718, of Cinnamomum sp. Compounds (143) and (144) show antimycobacterial activities against M. tuberculosis strain H37Rv in vitro showing MIC values of ≤5.12 and ≤2.52 μ g/mL, respectively, than the clinical drug Ethambutol (MIC 6.25 μ g/mL). Compounds (145–149) show moderate to weak antimycobacterial activities with MICs of 12.5, 25.0, 42.1, 58.2, and 50.0 μ g/mL, respectively (Cheng et al., 2012).

Dothideomycetide A (150) (Figure 10) from an endophyte a Dothideomycete sp., of a Thai medicinal plant, Tiliacora triandra, has antibacterial activity against S. aureus ATCC 25923 and MRSA ATCC 33591 with MIC values of 128 and 256 μ g/ mL respectively (Senadeera et al., 2012).

Cristatumins A (151) and Tardioxopiperazine A (152) (Figure 10) were produced by the endophyte Eurotium cristatum EN-220 of marine alga Sargassum thunbergii and showed activity against E. coli and S. aureus with MIC values of 64 and 8 μ g/mL, respectively (Du et al., 2012).

Compounds produced by hyphomycetes

Hyphomycete form a class of fungi which produces the asexual spores. Producers of the antibacterials Penicillins and Cephalosporins belong to this class. Other antibacterials from this class are Helvolic acid (141) (Figure 10), Monomethylsulochrin (138) (Figure 9), Ergosterol (79) (Figure 5) and 3β-Hydroxy-5α, 8α-epidioxy-ergosta-6, 22-diene (153) (Figure 11) were isolated from an endophyte Aspergillus sp. CY725 of Cynodon dactylon (Poaceae). Compounds (141), (138), (79), and (153) are active against H. pylori with MICs of 8.0, 10.0, 20.0, and 30.0 μ g/mL respectively. Helvolic acid (141) is active against Sarcina lutea and S. aureus with MICs of 15.0 and 20.0 μ g/mL respectively (Li et al., 2005).

Figure 11

Structures of antibacterial metabolites isolated from Hyphomycetes (153–165).

Aspergicin (154) and Neoaspergillic acid (155) (Figure 11) were isolated from a mixture of cultured mycelia of two marine-derived mangrove epiphytic Aspergilli FSY-01 and FSW-02. Aspergicin (154) has anti-bacterial activity against S. aureus, S. epidermidis, B. subtilis, B. dysenteriae, B. proteus, and E. coli, with MICs of 62.5, 31.25 15.62, 15.62 62.5, and 31.25 μ g/mL respectively. Neoaspergillic acid (155) has antibacterial activity against S. aureus, S. epidermidis, B. subtilis, B. dysenteriae, B. proteus, and E. coli, with MICs of 0.98, 0.49, 1.95, 7.8, 7.8, and 15.62 μ g/mL respectively (Zhu et al., 2011).

Two new dihydroisocoumarin derivatives Aspergillumarins A (156) and B (157) (Figure 11) are produced by a marine-derived Aspergillus sp., of the mangrove Bruguiera gymnorrhiza collected from the South China Sea. Both show weak antibacterial activities against S. aureus and B. subtilis at 50 μ g/mL (Li et al., 2012).

Brevianamide M (158), 6, 8-di-O-methylaverufin (159) and 6-O-Methylaverufin (160) (Figure 11), were isolated from Aspergillus versicolor a fungus of the marine brown alga Sargassum thunbergii. These compounds have activities against S. aureus and E. coli (Miao et al., 2012).

Isorhodoptilometrin-1-Me ether (161), Siderin (162) (Figure 11), were isolated from the marine fungus Aspergillus versicolor of inner tissues of the Red Sea green alga Halimeda opuntia. Both the compounds show moderate activity against Bacillus cereus, B. subtilis, and S. aureus at a concentration of 50 μg/disc of 9 mm (Hawas et al., 2012).

Yicathin B (163) and C (164) (Figure 11) were isolated from the endophyte Aspergillus wentii PT-1 of the red marine alga Gymnogongrus flabelliformis. Tested in the agar diffusion assay at 10 mg/disk compound (163) was active against E. coli (inhibition zone diameter 9 mm) and (164) a zone diameter of 12.0 mm and against S. aureus 7.5 mm (Sun et al., 2013b).

The alkaloids, Fumigaclavine C (165) (Figure 11) and Pseurotin A (166) (Figure 12) were isolated from the endophyte Aspergillus sp. EJC08, of the medical plant Bauhinia guianensis. Fumigaclavine C (165) has activity against B. subtilis, E. coli, P. aeruginosa, and S. aureus with MICs of 7.81, 62.50, 31.25, and 15.62 μ g/mL respectively, while Pseurotin A (166) has activity against B. subtilis, E. coli, P. aeruginosa, and S. aureus with MICs of 15.62, 31.25, 31.25, and 15.62 μ g/mL respectively (Pinheiro et al., 2013).

Figure 12

Structures of antibacterial metabolites isolated from Hyphomycetes (166–177).

Pseurotin A (166) (Figure 12) was isolated from Penicillium janczewskii of the Chilean gymnosperm Prumnopitys andina. The compound shows moderate activity against phytopathogenic bacteria Erwinia carotovora and Pseudomonas syringae, with IC50 values of 220 and 112 μ g/ mL, respectively (Schmeda-Hirschmann et al., 2008).

(+)-Sclerotiorin (167) (Figure 12), was isolated from the endophyte Penicillium sclerotiorum PSU-A13 (Arunpanichlert et al., 2010). Compound (167) has been reported to have antibacterial activity against S. aureus ATCC 29213 (MIC 128 μg/mL) (Lucas et al., 2007).

Emodin (168) and Erythritol (169) (Figure 12) were isolated from the endophyte Penicillium citrinum strain ZD6 of the stems of Bruguiera gymnorrhiza. Emodin (168) and Erythritol (169) inhibit the growth of B. subtilis with MIC values of 25 μ g/mL and 50 μ g/mL respectively, while Emodin (168) was weakly active against P. aeruginosa at an MIC value of 100 μ g/mL (Li et al., 2010).

Antibacterial Conidiogenone B (170) and Conidiogenol (171) (Figure 12) were isolated from Penicillium chrysogenum QEN-24S, an endophyte of a marine red algal species of the genus Laurencia. Conidiogenone B (170) has potent activity against MRSA, Pseudomonas fluorescens, P. aeruginosa, and S. epidermidis (at a concentration of 8 μ g/mL), while Conidiogenol (171) is activity against P. fluorescens and S. epidermidis (both at an MIC value of 16 μ g/mL) (Gao et al., 2011).

(3, 1′-didehydro-3[2″ (3‴, 3‴;-dimethyl-prop-2-enyl)-3″-indolylmethylene]-6-Mepipera-zine-2, 5-dione) (172) (Figure 12) was isolated from Penicillium chrysogenum MTCC 5108, an endophyte of the mangrove plant Porteresia coarctata (Roxb.), which has significant activity against Vibrio cholera MCM B-322 (Devi et al., 2012).

Perinadine A (173), Alternariol (174), and Citrinin (175) (Figure 12) were isolated from Penicillium citrinum present on the flowers of Ocimum tenuiflorum (Lamiaceae) collected in Denpasar, Bali, Indonesia. Compounds (173–175) were moderately active against S. aureus ATCC 29213 (MICs 64 μ g/mL). These compounds, failed to inhibit the E. coli ATCC 25922, and P. aeruginosa B 63230 at 64 μ g/mL (Lai et al., 2013).

Fusarusides (2S,2′R,3R,3′E,4E,8E,10E)-1-O-β-D-glucopy-ranosyl-2-N-(2′-hydroxy-3′-octadecenoyl)-3-hydroxy-9-methyl-4,8,10-sphingatrienine (176), (2S,2′R,3R,3′E,4E,8E)-1-O-β-D-glucopyranosyl-2-N-(2′-hydroxy-3′-octadecenoyl)-3-hydroxy-9-methyl-4,8-sphingadienine (177) (Figure 12) were isolated from a Fusarium sp. IFB-121, an endophyte of Quercus variabilis. Both cerebrosides have strong antibacterial activities against B. subtilis, E. coli and P. fluorescens with MIC values of 3.9, 3.9 and 1.9 μ g/mL and 7.8, 3.9, and 7.8 μ g/mL respectively (Shu et al., 2004).

Fusapyridon A (178) (Figure 13) was isolated from Fusarium sp. YG-45, an endophyte of the stem of Maackia chinensis, collected at Gottingen (Germany). The compound is active against P. aeruginosa and S. aureus, with MIC values of 6.25 and 50 μ g/mL, respectively (Tsuchinari et al., 2007).

Figure 13

Structures of antibacterial metabolites isolated from Hyphomycetes (178–189).

Beauvericin (179) (Figure 13) was found in the endophyte Fusarium redolens Dzf2, of the rhizomes of Dioscorea zingiberensis. The IC50 values of Beauvericin against six test bacteria viz. B. subtilis, Staphylococcus hemolyticus, Pseudomonas lachrymans, Agrobacterium tumefaciens, E. coli and X. vesicatoria were between 18.4 and 70.7 μ g/mL (Xu et al., 2010b). Beauvercin and (−)-4, 6′-anhydro-oxysporidinone (180) (Figure 13) were isolated from the endophyte Fusarium oxysporum of the bark of Cinnamomum kanehirae from Jiaoban Mountain, Taiwan Province. Beauvericin (179) is active against MRSA and B. subtilis at MICs of 3.125 μ g/mL. (−)-4, 6′-anhydro-oxysporidinone (180) has weak anti-MRSA activity (MIC, 100 μ g/mL) and moderate activity against B. subtilis (MIC, 25 μ g/mL) (Wang et al., 2011).

Javanicin (181), 3-O-methylfusarubin (182), a diastereomer of Dihydronaphthalenone (183) and 5-Hydroxy-3-methoxydihydrofusarubin A (184) (Figure 13) were isolated from the endophyte Fusarium sp. BCC14842 of Bamboo leaf, collected from the Bamboo forest at Nam Nao National Park, Phetchabun Province, Thailand. Compound (181), and (183) have moderate activities (MICs of 25 μ g/mL) while 3-O-methylfusarubin (182) and 5-hydroxy-3-methoxydihydrofusarubin A (184) showed weak antimycobacterial activity (MICs of 50 μ g/mL) (Kornsakulkarn et al., 2011).

Fusaric acid was obtained from a Fusarium sp. an endophyte of a mangrove plant. Cadmium and Copper metal complexes were prepared. The Cadmium (185) and Copper (186) (Figure 13) complexes of fusaric acid exhibited potent inhibitory activity against the Mycobacterium bovis BCG strain with MIC 4 μ g/mL and the M. tuberculosis H37Rv strain with MIC 10 μ g/mL respectively (Pan et al., 2011).

Fumitremorgin B (187), Fumitremorgin C (188), Helvolic acid (141), Bisdethiobis (methylthio) gliotoxin (189) (Figure 13), Bis-N-norgliovietin (190) and Gliotoxin (191) (Figure 14) were isolated from the endophyte Fusarium solani of Ficus carica. All compounds are active against B. subtilis, S. aureus, and E. coli and P. aeruginosa with MICs in the range of 0.5–16 μg/mL (Zhang et al., 2012).

Figure 14

Structures of antibacterial metabolites isolated from Hyphomycetes (190–204).

Lateropyrone (192), Enniatins B1 (193) and A1 (194) (Figure 14), were isolated from mix culture fermentation of the fungal endophyte Fusarium tricinctum and the bacterium B. subtilis 168 trpC2 on solid rice medium. Fusarium tricinctum was obtained from rhizomes of Aristolochia paucinervis of the mountains of Beni-Mellal, Morocco. Enniatins B1 (193) and A1 (194), inhibit the growth the B. subtilis strain (MICs of 16 and 8 μ g/mL, respectively) and were also active against S. aureus, S. pneumoniae, and E. faecalis with MIC values in the range 2-8 μ g/mL. Lateropyrone (192) has antibacterial activity against B. subtilis, S. aureus, S. pneumoniae and E. faecalis, with MICs values ranging from 2 to 8 μ g/mL. All the above compounds were equally effective against a multi-drug-resistant clinical isolate of S. aureus (Ola et al., 2013).

Rhein (195) (Figure 14) was isolated from an endophyte Fusarium solani of Rheum palmatum collected at Ruoergai County, Sichuan Province, China. Rhein (195) naturally occurs in anthraquinone (1, 3, 8-trihydroxy-6-Me anthraquinone), that is found in Rheum palmatum L. and related plants such as rhubarb (You et al., 2013). It has good antibacterial activity with MICs in the range of 0.6–4 μg/mL against S. aureus, S. aureus nor A, B. megaterium 11561, Pseudomonas syringae and Sinorhizobium meliloti (Tegos et al., 2002).

Sanguinarine (196) (Figure 14), a benzophenanthridine alkaloid was obtained from the endophyte Fusarium proliferatum (strain BLH51) present on the leaves of Macleaya cordata of the Dabie Mountain, China. It has antibacterial, anthelmintic, and anti-inflammatory activities (Wang et al., 2014). It has antibacterial activities against the range of bacteria with MICs of 3.12–6.25 μg/mL against 15 clinical isolates of S. aureus while the MICs against of the two reference strains are 3.12 μg/mL for ATCC 25923 and 1.56 μg/mL for ATCC 33591.

The clinical isolates strains showed MIC values ranging from 31.25 to 250 μg/mL for ampicillin and 125–1000 μg/mL for ciprofloxacin. The treatment of the cells with sanguinarine induced the release of membrane-bound cell wall autolytic enzymes, which eventually resulted in lysis of the cell. Transmission electron microscopy (TEM) of MRSA treated with Sanguinarine show alterations in septa formation. The predisposition of lysis and altered morphology seen by TEM indicates that sanguinarine acts on the cytoplasmic membrane (Obiang-Obounou et al., 2011). The compound also has activity against plaque bacteria with MICs of 1–32 μg/mL for most species tested. The Electron microscopic studies of bacteria exposed to sanguinarine show that they aggregate and become morphologically irregular (Godowski, 1989).

Shikimic acid (197) (Figure 14), was obtained from the endophyte Trichoderma ovalisporum strain PRE-5 of the root of the herbal Panax notoginseng. The compound (197) is activity against S. aureus, Bacillus cereus, M. luteus and E. coli (Dang et al., 2010).

Trichoderic acid (198), 2β-Hydroxytrichoacorenol (199), Cyclonerodiol (200), Cyclonerodiol oxide (201), and Sorbicillin (202) (Figure 14), were isolated from a Trichoderma sp. PR-35, an endophyte of Paeonia delavayi. These compounds are active against E. coli and S. albus with minimal inhibitory amount (MIA) values in the range of 25–150 mg/disk. Compounds (198), (200) and (201) are active against Shigella sonnei with MIA values in the range of 100–150 μg/disk (Wu et al., 2011).

Cyclopeptides PF1022F (203) and Halobacillin (204) (Figure 14), were isolated from the endophyte Trichoderma asperellum from traditional Chinese medicinal plant Panax notoginseng. Compounds (203) and (204) are active against E. faecium (CGMCC 1.2025) with IC50 values of 7.30 and 5.24 μ M and against S. aureus COL (CGMCC 1.2465) with IC50 values of 19.02 and 14.00 μ M, respectively (Ding et al., 2012).

Tetrahydrobostrycin (205), 4-Deoxytetrahydrobostrycin (206), 3,6,8-Trihydroxy-1- methylxanthone (207), Griseophenone C (208) and 2,3-Didehydro-19α-hydroxy-14-epicochlioquinone B (209) (Figure 15), were isolated from the endophyte Nigrospora sp. MA75, of the mangrove plant Pongamia pinnata collected from Guangxi Zhuang Autonomous Region of China. Compound (209) has excellent activity against all the tested bacteria (MRSA, E. coli, P. aeruginosa, P. fluorescens and S. epidermidis) with MIC values of 8, 4, 4, 0.5, and 0.5 μg/mL, respectively. The activity toward E. coli, P. fluorescens and S. epidermidis was stronger than that of the positive control (Ampicillin, with MICs values of 8, 4, and 4 μg/mL, respectively). Compound (208) strongly inhibits MRSA, E. coli, P. aeruginosa, and P. fluorescens at MIC values of 0.5, 2, 0.5, and 0.5 μg/mL, respectively. Compound (205) has significant activity toward MRSA and E. coli (MIC 2 and 0.5 μg/mL, respectively), while its analog compound (206), is only activity against E. coli (MIC 4 μg/mL). This indicates that the OH group at C (4) could be important for the activity against MRSA. Compound (207) is active only against S. epidermidis (MIC 0.5 μg/mL) (Shang et al., 2012).

Figure 15

Structures of antibacterial metabolites isolated from Hyphomycetes (205–218).

4-Deoxybostrycin (210) and its derivative Nigrosporin (211) (Figure 15), were isolated from the mangrove endophyte Nigrospora sp. of the South China Sea. These compounds are active against M. tuberculosis and clinical multidrug-resistant (MDR) M. tuberculosis strains with MIC values of <5–> 60 μ g/mL (Wang et al., 2013b).

Periconicins A (212) and B (213) (Figure 15), were isolated from an endophyte Periconia sp., from the branches of Taxus cuspidata. Periconicin A (212) has significant activity against B. subtilis, S. aureus, K. pneumoniae, and Salmonella typhimurium with MICs in the range of 3.12–12.5 μ g/mL. Periconicin B (213) has modest antibacterial activity against the same strains with MICs in the range 25–50 μ g/mL (Kim et al., 2004).

Piperine (214) (Figure 15), which was originally isolated from Piper longum, was also detected from the endophyte Periconia sp. of the same plant. Piperine has strong activity against M. tuberculosis and M. smegmetis with MICs of 1.74 and 2.62 μ g/mL respectively (Verma et al., 2011).

Modiolide A, 5, 8-dihydroxy-10-methyl-5, 8, 9, 10-tetrahydro-2H-Oxecin-2-one (215) and 4-Chromanone, 6-hydroxy-2-methyl- (5CI) (216) (Figure 15) were isolated from the endophyte Periconia siamensis (strain CMUGE015) of the leaves of the grass, Thysanoleana latifolia (Poaceae). Compound (215) is active against Bacillus cereus, Listeria monocytogenes, MRSA, P. aeroginosa and E. coli with MIC of 3.12, 6.25, 25.00, 12.50, and 50.00 μ g/mL respectively. Compound (216) is active against B. cereus, Listeria monocytogenes, MRSA, P. aeruginosa and E. coli with MICs of 6.25, 12.50, 50.00 25.00, 12.50, and 100.00 μ g/mL respectively (Bhilabutra et al., 2007).

Xanalteric acids I (217) and II (218) (Figure 15) and Altenusin (219) (Figure 16), were obtained from Alternaria sp., of the mangrove plant Sonneratia alba. These (217–218) has weak antibacterial activities against MRSA with MICs of 125 and 250 μ g/mL. Altenusin (219) exhibited broad antimicrobial activity against several resistant pathogens (MRSA, S. pneumonia, E. faecium, E. cloacae and A. faecalis) with MIC values of 31.25–125 μ g/mL (Kjer et al., 2009).

Figure 16

Structures of antibacterial metabolites isolated from Hyphomycetes (219–232).

1-(2, 6-dihydroxyphenyl) butan-1-one (220) (Figure 16), was isolated from the endophyte Nodulisporium sp. of Juniperus cedrus from Gomera Island. Compound (220) is active against B. megaterium at 0.25 mg/filter disc with 15 mm zone of inhibition (Dai et al., 2006).

Nodulisporins D-F (221–223), Benzene- 1, 2, 3-triol (224) (Figure 16), were isolated from an endophyte Nodulisporium sp. of Erica arborea. Compounds (221–224) showed activity against B. megaterium (Dai et al., 2009b).

Pyrrocidine (113) (Figure 9), was isolated from Acremonium zeae an endophyte of maize. Compound (113) has potent activity against Clavibacter michiganense subsp. Nebraskense a causal agent of Goss's bacterial wilt of maize (MICs 1–2 μ g/mL), as well as Bacillus mojavensis (MICs 1–2 μ g/mL) and P. fluorescens (MICs 1–2 μ g/mL) (Wicklow and Poling, 2009).

Rhizoctonic acid (139), Monomethylsulochrin (138) (Figure 9), Ergosterol (79) (Figure 5) and 3β, 5α, 6β-trihydroxyergosta-7, 22-diene (225) (Figure 16), were isolated from a Rhizoctonia sp. (Cy064), the endophyte in the leaves of Cynodon dactylon. Compounds (139, 138, 79, and 225) are active against five clinical and one reference strain of H. pylori (ATCC 43504) with MICs in the range 10.0–30.0 μ g/mL (Ma et al., 2004).

Ophiobolins P (226) and T (227) (Figure 16), were isolated from the endolichenic fungus Ulocladium sp. Ophiobolins P has moderate antibacterial activity against B. subtilis and MRSA with MICs of 62.5 and 31.3 μ g/mL respectively. Ophiobolin T (227) has moderate activity against B. subtilis and MRSA and Bacille Calmette-Guerin strain with MICs of 31.3 15.6 and 31.3 μ g/mL respectively (Wang et al., 2013a).

The antibacterial naphthaquinone Javanicin (181) (Figure 13) was isolated from an endophyte Chloridium sp. of Azadirachta indica. This compound is very active against P. fluorescens and P. aeruginosa with MIC of 2 μ g/mL (Khrawar et al., 2009).

(3S)-Lasiodiplodin (228), (R)-(−)-Mellein (229), Cis-(3R, 4R)-(−)-4-Hydroxymellein (230), trans-(3R, 4S)-(−)-4-Hydroxymellein (231), (R)-(−)-5-Hydroxymellein (232) (Figure 16) were isolated from the endophyte Botryosphaeria rhodina PSU-M35 and PSU-M114. Compound (228) is very active against S. aureus and MRSA with MIC values of 64 and 128 μ g/mL respectively. Compounds (229–232) have much weaker activities than compound (228) with MIC values >128 μ g/mL (Rukachaisirikul et al., 2009).

Fusidilactones D (233) and E (234) (Figure 17) were isolated from the endophyte, a Fusidium sp. from the leaves of Mentha arvensis growing in a meadow near Hahausen, Lower Saxony, Germany. Both compounds are weakly active against E. coli and B. megaterium (Qin et al., 2009).

Figure 17

Structures of antibacterial metabolites isolated from Hyphomycetes (233–241).

Palmariol B (235), 4-Hydroxymellein (236), Alternariol 9-methyl ether (237) and Botrallin (238) (Figure 17) were isolated from an endophyte, Hyalodendriella sp. Ponipodef 12, of the hybrid “Neva” of Populus deltoides Marsh × P. nigra L. MIC50 values of the compounds on Agrobacterium tumefaciens ranged from 18.22 to 87.52 μ g/mL. Against B. subtilis, P. lachrymans, R. solanacearum and X. vesicatoria, MICs50 were from 19.22 to 98.47, 16.18 to 92.21, 16.24 to 85.46 and 17.81 to 86.32 μ g/mL respectively (Meng et al., 2012).

Alterporriol N (239), Alterporriol D (240), and Alterporriol E (241) (Figure 17), were isolated from Stemphylium globuliferuman an endophyte of Mentha pulegium collected from Morocco. Alterporriol N (239) is active against MRSA and E. faecalis with MICs of 62.5 and 15.63 μ g/mL. Alterporriol D (240) is active against MRSA and Streptomyces pneumonia with an MIC of 31.25 μ g/mL. Alterporriol E (241) is active against S. pneumonia, E. faecalis and Enterobacter cloacae with MICs of 31.25 μ g/mL each (Debbab et al., 2009).

Compounds produced from unidentified fungi

Nonsporulating fungi form a major group of such endophytes. Khafrefungin, Arundifungin are antifungals reported from such fungi (Deshmukh and Verekar, 2012). Bostrycin (242) (Figure 18) isolated from the mangrove endophyte, no. 1403, of the South China Sea (Xu et al., 2010a), shows antibacterial activity against B. subtilis (Charudattan and Rao, 1982).

Figure 18

Structures of antibacterial metabolites isolated from Unidentified fungus (242–256).

Guanacastepene A (243) (Figure 18), a novel diterpenoid produced the fungus CR115 isolated from the branch of Daphnopsis americana growing in Guanacaste, Costa Rica, may prove to belong to potentially new class of antibacterial agents with activities against MRSA and VRE (Singh et al., 2000). Guanacastepene I (244) (Figure 18), was isolated from the same fungus is active against S. aureus (Brady et al., 2001).

Anhydrofusarubin (245) (Figure 18), was isolated from the endophyte no. B77 of a mangrove tree on the South China Sea coast. Compound (245) is active against Staphylococcus aureus (ATCC27154) with a MIC of 12.5 μ g/mL (Shao et al., 2008b).

3-O-Methylfusarubin (182) (Figure 13), Fusarubin (246) (Figure 18), were isolated from the endophyte B77 present in the seeds of the mangrove plant Kandelia candel in Zhanjiang. Compounds (182) and (246) were active against S. aureus ATCC 27154 with MIC values of 50.0 and 12.5 μ g/mL, respectively (Shao et al., 2008a).

Compound (247), 9α –Hydroxyhalorosellinia A (248) and Desoxybostrycin (249) (Figure 18), were isolated from the endophyte PSU-N24 present in the plant Garcinia nigrolineata collected from the Ton Nga Chang wildlife sanctuary, Songkhla province, southern Thailand. Compound (248) was active against M. tuberculosis with the MIC value of 12.50 μ g/mL whilst compounds (247) and (249) had MIC values of 25 and 50 μ g/mL, respectively (Sommart et al., 2008).

Indolyl-3-carboxylic acid (250) (Figure 18), isolated from the endophyte S20 of Cephalotaxus hainanensis Li. showed inhibition of S. aureus and MRSA with diameters of inhibition zones of which were 12 and 8 mm, respectively when 50 μ l of the compound (10 mg/mL) impregnated on sterile filter paper discs (6-mm diameter) (Dai et al., 2009a). The structure of a new 5-acyl-2-methylpyrrole (251) (Figure 18) from the same endophyte S20 of Cephalotaxus hainanensis, was shown to be 1-(5-methyl-1H-pyrrol-2-yl)-2-((2S*, 3R*)-3-((E)-prop-1-enyl) oxiran-2-yl) ethanone. Compound (251) is active against S. aureus and MRSA. The diameters of inhibition are 12.0 mm and 10.0 mm respectively when 50 μ L (10 mg/mL) of the compound was impregnated on sterile filter paper discs (6-mm diameter) (Dai et al., 2009c).

Spirobisnaphthalenes, namely Diepoxin κ (252), Diepoxin η (253), and Diepoxin ζ (254) (Figure 18), were isolated from the endophyte Dzf12 of the medicinal plant Dioscorea zingiberensis. Among these, compound (252) has antibacterial activity, against E. coli, A. tumefaciens, X. vesicatoria, P. lachrymans and B. subtilis with MICs from 50 to 100 μ g/mL. A mixture of diepoxin η (253), and diepoxin ζ (254) showed antibacterial activity against the same set of bacteria with a MICs range of 5.0–12.5 μ g/mL (Cai et al., 2009).

4-Hydroxyphthalide (255), 5-methoxy-7-hydroxyphthalide (256), (3R, 4R)-cis-4 hydroxymellein (257) (Figure 19), were obtained from an unidentified Ascomycete from Meliotus dentatus of the coastal area of the Baltic Sea, Ahrenshoop, Germany. Compounds (255) and (256) were active against E. coli whereas (256) and (257) were active against B. megaterium (Hussain et al., 2009b).

Figure 19

Structures of antibacterial metabolites isolated from Unidentified fungus (257–265).

Pestalotheols E-H (258–261) and Anofinic acid (262) (Figure 19), were obtained from an unidentified ascomycete of Arbutus unedo. Compounds (258–262) have antibacterial activity against E. coli and B. megaterium (Qin et al., 2011).

Guignardone I (263) and Guignardone B (264) (Figure 19), were isolated from an endophyte fungus A1 of the mangrove plant Scyphiphora hydrophyllacea. Guignardone I (263) shows zones inhibition of 9.0 and 11.0 mm in diameter, using 6 mm filter paper discs toward MRSA and S. aureus at 65 μ M, respectively. Guignardone B (264) shows zones of 8.0 mm against MRSA at 65 μ M. Kanamycin sulfate, used as positive control (10 μ L of 0.08 mg/mL) showed an inhibition zone of 30 mm (Mei et al., 2012).

Mirandamycin (265) (Figure 19) was obtained from isolate 1223-D, an unclassified fungus of twig of Neomirandea angularis of family Asteraceae. It is active against E.coli 25922, P. aeruginosa 27853, K. pneumoniae carbapenemase positive BAA-1705, MRSA BAA-976 and V. cholerae PW357 with MICs of 80, 80, >80, 10, and 40 μg/mL respectively (Ymele-Leki et al., 2012).

Volatile organic compounds from endophytic fungi

Strobel et al. (2001) reported at least 28 volatile organic compounds (VOC) from the xylariaceaous endophyte Muscodor albus (isolate 620), of Cinnamomum zeylanicum from Lancetilla Botanical Garden near La Ceiba, Honduras. These VOC's are mixtures of gasses of five class's viz. alcohols, acids, esters, ketones and lipids. The most effective were the esters, of which, 1-butanol, 3-methyl-acetate has the highest activity. The VOC's inhibited and killed certain bacteria, within a period of 1–3 days. Most test organisms were completely inhibited, and in fact killed. These includes Escherichia coli, Staphylococcus aureus, Micrococcus luteus and Bacillus subtilis along with some fungal species.

Strain of Muscodor namely Muscodor crispans of Ananas ananassoides (wild pineapple) growing in the Bolivian Amazon Basin produces VOC's; namely propanoic acid, 2-methyl-; 1-butanol, 3-methyl-; 1-butanol, 3-methyl-, acetate; propanoic acid, 2-methyl-, 2-methylbutyl ester; and ethanol. The VOC's of this fungus are effective against Xanthomonas axonopodis pv. citri a citrus pathogens. The VOC's of M. crispans kill several human pathogens, including Yersinia pestis, Mycobacterium tuberculosis and Staphylococcus aureus. Muscodor crispans is only effective against the vegetative cells of Bacillus anthracis, but not against the spores. Artificial mixtures of the fungal VOC's were both inhibitory and lethal to a number of human and plant pathogens, including three drug-resistant strains of Mycobacterium tuberculosis (Mitchell et al., 2010). The mechanism of action of the VOC's of Muscodor spp. on target bacteria is unknown. A microarray study of the transcriptional response analysis of B. subtilis cells exposed to M. albus VOC's show that the expression of genes involved in DNA repair and replication increased, suggesting that VOC's induce some type of DNA damage in cells, possibly through the effect of one of the naphthalene derivatives (Mitchell et al., 2010).

Outlook

A definite, urgent and worldwide effort is needed to tackle the problems of the populations in third world and developing countries. MRSA, VRE, PRSP, ESCAPE organisms have spread through these countries over the years particularly due to immunocompromised populations. Mycobacterium tuberculosis is a major threat! and New and Novel drugs are a must!! Endophytic fungi may be an excellent source of such compounds. These organisms have a vast repertoire of diverse chemicals such as steroids, xanthones, phenols, isocoumarins, perylene derivatives, quinones, furandiones, terpenoids, depsipeptides and cytochalasins (Tan and Zou, 2001; Gunatilaka, 2006; Zhang et al., 2006; Guo et al., 2008).

A major challenge in Drug Discovery Program based on endophytic fungi lies in developing effective strategies to isolating bioactive strains. Strobel and Daisy (2003) suggested that areas of high biodiversity of endemic plant species may hold the greatest potential for endophytes with novel chemical entities. Tropical forests are some of the most bio diverse ecosystems and their leaves are “biodiversity hotspots” (Arnold and Lutzoni, 2007). The selection of plants is crucial. Those with medicinal properties should be given preference. Metabolites produced by fungi need to correlated with the plant genomics, thus allowing far better knowledge of biosynthetic pathways. This will also justify the production of metabolites rather than unproven hypotheses.

Identification of endophytic fungi using molecular analyses provides an opportunity to look for broad patterns in bioactivity not only at the genotype or strain level, but at higher taxonomic levels that may in turn assist in focusing on the association of metabolite with the plant.

The endophytic flora of the Indian subcontinent has been explored for their diversity but not enough for their bioactive metabolites. The published work is scanty (Puri et al., 2005; Deshmukh et al., 2009; Khrawar et al., 2009; Periyasamy et al., 2014). There is a need for groups from different scientific discipline (mycologist, chemist, toxicologist, and pharmacologist) to engage in this search process. Enormous natural wealth exists in the world's tropical forests, but disparity exists between developed countries with their financial resources and biodiversity rich countries with underdeveloped economy and limited funds. May be funding agencies need to look at such aspects.

The need of a more and larger collection of fungal endopytes is suggested. Bioactive metabolite metabolites from such collections could yield leads for pharmaceutical and agricultural application.

What emerges is the essential bonding of various discipline of biology and chemistry into cohesive target delivery vehicles.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.